ID   THRB_HUMAN              Reviewed;         622 AA.
AC   P00734; B2R7F7; B4E1A7; Q4QZ40; Q53H04; Q53H06; Q69EZ7; Q7Z7P3;
AC   Q9UCA1;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1990, sequence version 2.
DT   10-MAY-2017, entry version 229.
DE   RecName: Full=Prothrombin;
DE            EC=3.4.21.5;
DE   AltName: Full=Coagulation factor II;
DE   Contains:
DE     RecName: Full=Activation peptide fragment 1;
DE   Contains:
DE     RecName: Full=Activation peptide fragment 2;
DE   Contains:
DE     RecName: Full=Thrombin light chain;
DE   Contains:
DE     RecName: Full=Thrombin heavy chain;
DE   Flags: Precursor;
GN   Name=F2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=2825773; DOI=10.1021/bi00393a033;
RA   Degen S.J.F., Davie E.W.;
RT   "Nucleotide sequence of the gene for human prothrombin.";
RL   Biochemistry 26:6165-6177(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT FA2D GLY-72.
RC   TISSUE=Blood;
RX   PubMed=14962227; DOI=10.1046/j.1365-2516.2003.00838.x;
RA   Wang W., Fu Q., Zhou R., Wu W., Ding Q., Hu Y., Wang X., Wang H.,
RA   Wang Z.;
RT   "Prothrombin Shanghai: hypoprothrombinaemia caused by substitution of
RT   Gla29 by Gly.";
RL   Haemophilia 10:94-97(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT MET-165.
RC   TISSUE=Liver, and Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT MET-165.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JAN-2002) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 8-622, AND GAMMA-CARBOXYGLUTAMATION AT
RP   GLU-49; GLU-50; GLU-57; GLU-59; GLU-62; GLU-63; GLU-68; GLU-69; GLU-72
RP   AND GLU-75.
RX   PubMed=6305407; DOI=10.1021/bi00278a008;
RA   Degen S.J.F., McGillivray R.T.A., Davie E.W.;
RT   "Characterization of the complementary deoxyribonucleic acid and gene
RT   coding for human prothrombin.";
RL   Biochemistry 22:2087-2097(1983).
RN   [8]
RP   PROTEIN SEQUENCE OF 44-64.
RC   TISSUE=Urine;
RX   PubMed=8073540; DOI=10.1007/BF00431548;
RA   Suzuki K., Moriyama M., Nakajima C., Kawamura K., Miyazawa K.,
RA   Tsugawa R., Kikuchi N., Nagata K.;
RT   "Isolation and partial characterization of crystal matrix protein as a
RT   potent inhibitor of calcium oxalate crystal aggregation: evidence of
RT   activation peptide of human prothrombin.";
RL   Urol. Res. 22:45-50(1994).
RN   [9]
RP   PROTEIN SEQUENCE OF 44-314.
RX   PubMed=266717; DOI=10.1073/pnas.74.5.1969;
RA   Walz D.A., Hewett-Emmett D., Seegers W.H.;
RT   "Amino acid sequence of human prothrombin fragments 1 and 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 74:1969-1972(1977).
RN   [10]
RP   PROTEIN SEQUENCE OF 315-622, GLYCOSYLATION AT ASN-416, AND VARIANT
RP   GLN-532.
RX   PubMed=873923;
RA   Butkowski R.J., Elion J., Downing M.R., Mann K.G.;
RT   "Primary structure of human prethrombin 2 and alpha-thrombin.";
RL   J. Biol. Chem. 252:4942-4957(1977).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 364-622.
RA   Gruber A., Hanson S.R., DiCera E.;
RT   "Antithrombotic thrombin variants.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   ENZYME REGULATION, AND HETERODIMER WITH SERPINA5.
RX   PubMed=6323392;
RA   Suzuki K., Nishioka J., Kusumoto H., Hashimoto S.;
RT   "Mechanism of inhibition of activated protein C by protein C
RT   inhibitor.";
RL   J. Biochem. 95:187-195(1984).
RN   [13]
RP   PROTEOLYTIC PROCESSING, AND GAMMA-CARBOXYGLUTAMATION AT GLU-49 AND
RP   GLU-50.
RX   PubMed=3759958;
RA   Rabiet M.J., Blashill A., Furie B., Furie B.C.;
RT   "Prothrombin fragment 1 X 2 X 3, a major product of prothrombin
RT   activation in human plasma.";
RL   J. Biol. Chem. 261:13210-13215(1986).
RN   [14]
RP   FUNCTION, AND CHARACTERIZATION.
RX   PubMed=2856554;
RA   Glenn K.C., Frost G.H., Bergmann J.S., Carney D.H.;
RT   "Synthetic peptides bind to high-affinity thrombin receptors and
RT   modulate thrombin mitogenesis.";
RL   Pept. Res. 1:65-73(1988).
RN   [15]
RP   INVOLVEMENT IN RPRGL2 SUSCEPTIBILITY.
RX   PubMed=11506076; DOI=10.1111/j.8755-8920.2001.460202.x;
RA   Pihusch R., Buchholz T., Lohse P., Rubsamen H., Rogenhofer N.,
RA   Hasbargen U., Hiller E., Thaler C.J.;
RT   "Thrombophilic gene mutations and recurrent spontaneous abortion:
RT   prothrombin mutation increases the risk in the first trimester.";
RL   Am. J. Reprod. Immunol. 46:124-131(2001).
RN   [16]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO ISCHSTR.
RX   PubMed=15534175; DOI=10.1001/archneur.61.11.1652;
RA   Casas J.P., Hingorani A.D., Bautista L.E., Sharma P.;
RT   "Meta-analysis of genetic studies in ischemic stroke: thirty-two genes
RT   involving approximately 18,000 cases and 58,000 controls.";
RL   Arch. Neurol. 61:1652-1661(2004).
RN   [17]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-121 AND ASN-143.
RC   TISSUE=Plasma;
RX   PubMed=14760718; DOI=10.1002/pmic.200300556;
RA   Bunkenborg J., Pilch B.J., Podtelejnikov A.V., Wisniewski J.R.;
RT   "Screening for N-glycosylated proteins by liquid chromatography mass
RT   spectrometry.";
RL   Proteomics 4:454-465(2004).
RN   [18]
RP   CHARACTERIZATION OF THE TP508 PEPTIDE.
RX   PubMed=15885491; DOI=10.1016/j.orthres.2004.12.005;
RA   Li G., Cui Y., McIlmurray L., Allen W.E., Wang H.;
RT   "rhBMP-2, rhVEGF(165), rhPTN and thrombin-related peptide, TP508
RT   induce chemotaxis of human osteoblasts and microvascular endothelial
RT   cells.";
RL   J. Orthop. Res. 23:680-685(2005).
RN   [19]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-121; ASN-143 AND ASN-416.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,
RA   Moore R.J., Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [20]
RP   THERAPEUTIC USAGE OF THE TP508 PEPTIDE.
RX   PubMed=17244316; DOI=10.1111/j.1524-475X.2006.00181.x;
RA   Fife C., Mader J.T., Stone J., Brill L., Satterfield K., Norfleet A.,
RA   Zwernemann A., Ryaby J.T., Carney D.H.;
RT   "Thrombin peptide Chrysalin stimulates healing of diabetic foot ulcers
RT   in a placebo-controlled phase I/II study.";
RL   Wound Repair Regen. 15:23-34(2007).
RN   [21]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-416.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [22]
RP   GLYCOSYLATION AT ASN-416.
RX   PubMed=19139490; DOI=10.1074/mcp.M800504-MCP200;
RA   Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F.,
RA   Zheng Z.B., Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y.,
RA   Zhang Y.K., Deng Y.L., Ying W.T., He S.M., Qian X.H.;
RT   "A strategy for precise and large scale identification of core
RT   fucosylated glycoproteins.";
RL   Mol. Cell. Proteomics 8:913-923(2009).
RN   [23]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-416, AND STRUCTURE OF
RP   CARBOHYDRATE.
RC   TISSUE=Cerebrospinal fluid;
RX   PubMed=19838169; DOI=10.1038/nmeth.1392;
RA   Nilsson J., Rueetschi U., Halim A., Hesse C., Carlsohn E.,
RA   Brinkmalm G., Larson G.;
RT   "Enrichment of glycopeptides for glycan structure and attachment site
RT   identification.";
RL   Nat. Methods 6:809-811(2009).
RN   [24]
RP   GLYCOSYLATION AT ASN-121 AND ASN-143, STRUCTURE OF CARBOHYDRATES, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=22171320; DOI=10.1074/mcp.M111.013649;
RA   Halim A., Nilsson J., Ruetschi U., Hesse C., Larson G.;
RT   "Human urinary glycoproteomics; attachment site specific analysis of
RT   N-and O-linked glycosylations by CID and ECD.";
RL   Mol. Cell. Proteomics 0:0-0(2011).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS).
RX   PubMed=2583108;
RA   Bode W., Mayr I., Baumann U., Huber R., Stone S.R., Hofsteenge J.;
RT   "The refined 1.9 A crystal structure of human alpha-thrombin:
RT   interaction with D-Phe-Pro-Arg chloromethylketone and significance of
RT   the Tyr-Pro-Pro-Trp insertion segment.";
RL   EMBO J. 8:3467-3475(1989).
RN   [27]
RP   X-RAY CRYSTALLOGRAPHY (2.95 ANGSTROMS) IN COMPLEX WITH HIRUDIN.
RX   PubMed=2369893;
RA   Gruetter M.G., Priestle J.P., Rahuel J., Grossenbacher H., Bode W.,
RA   Hofsteenge J., Stone S.R.;
RT   "Crystal structure of the thrombin-hirudin complex: a novel mode of
RT   serine protease inhibition.";
RL   EMBO J. 9:2361-2365(1990).
RN   [28]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH HIRUDIN.
RX   PubMed=2374926; DOI=10.1126/science.2374926;
RA   Rydel T.J., Ravichandran K.G., Tulinsky A., Bode W., Huber R.,
RA   Roitsch C., Fenton J.W. II;
RT   "The structure of a complex of recombinant hirudin and human alpha-
RT   thrombin.";
RL   Science 249:277-280(1990).
RN   [29]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 328-622 IN COMPLEXES WITH
RP   HIRUDIN AND SYNTHETIC INHIBITOR.
RX   PubMed=8251938; DOI=10.1002/pro.5560021009;
RA   Priestle J.P., Rahuel J., Rink H., Tones M., Gruetter M.G.;
RT   "Changes in interactions in complexes of hirudin derivatives and human
RT   alpha-thrombin due to different crystal forms.";
RL   Protein Sci. 2:1630-1642(1993).
RN   [30]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS).
RX   PubMed=8071320;
RA   Rydel T.J., Yin M., Padmanabhan K.P., Blankenship D.T., Cardin A.D.,
RA   Correa P.E., Fenton J.W. II, Tulinsky A.;
RT   "Crystallographic structure of human gamma-thrombin.";
RL   J. Biol. Chem. 269:22000-22006(1994).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS).
RX   PubMed=9214615; DOI=10.1093/emboj/16.11.2977;
RA   van de Locht A., Bode W., Huber R., le Bonniec B.F., Stone S.R.,
RA   Esmon C.T., Stubbs M.T.;
RT   "The thrombin E192Q-BPTI complex reveals gross structural
RT   rearrangements: implications for the interaction with antithrombin and
RT   thrombomodulin.";
RL   EMBO J. 16:2977-2984(1997).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 328-601.
RX   PubMed=10051558; DOI=10.1073/pnas.96.5.1852;
RA   Guinto E.R., Caccia S., Rose T., Fuetterer K., Waksman G., di Cera E.;
RT   "Unexpected crucial role of residue 225 in serine proteases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:1852-1857(1999).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS) OF 333-621 IN COMPLEX WITH
RP   SYNTHETIC INHIBITOR.
RX   PubMed=11493008; DOI=10.1006/jmbi.2001.4872;
RA   Skordalakes E., Dodson G.G., Green D.S., Goodwin C.A., Scully M.F.,
RA   Hudson H.R., Kakkar V.V., Deadman J.J.;
RT   "Inhibition of human alpha-thrombin by a phosphonate tripeptide
RT   proceeds via a metastable pentacoordinated phosphorus intermediate.";
RL   J. Mol. Biol. 311:549-555(2001).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.3 ANGSTROMS) OF 334-620 IN COMPLEX WITH
RP   HIRUDIN AND SYNTHETIC INHIBITOR.
RX   PubMed=16763681; DOI=10.1039/b602585d;
RA   Schweizer E., Hoffmann-Roeder A., Olsen J.A., Seiler P.,
RA   Obst-Sander U., Wagner B., Kansy M., Banner D.W., Diederich F.;
RT   "Multipolar interactions in the D pocket of thrombin: large
RT   differences between tricyclic imide and lactam inhibitors.";
RL   Org. Biomol. Chem. 4:2364-2375(2006).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (1.84 ANGSTROMS) OF 334-621 IN COMPLEX WITH
RP   HIRUDIN.
RX   PubMed=17685615; DOI=10.1021/ja0735002;
RA   Liu C.C., Brustad E., Liu W., Schultz P.G.;
RT   "Crystal structure of a biosynthetic sulfo-hirudin complexed to
RT   thrombin.";
RL   J. Am. Chem. Soc. 129:10648-10649(2007).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (1.84 ANGSTROMS) OF 335-621 IN COMPLEX WITH
RP   SYNTHETIC INHIBITOR.
RX   PubMed=18291642; DOI=10.1016/j.bmcl.2008.01.098;
RA   Isaacs R.C.A., Solinsky M.G., Cutrona K.J., Newton C.L.,
RA   Naylor-Olsen A.M., McMasters D.R., Krueger J.A., Lewis S.D.,
RA   Lucas B.J., Kuo L.C., Yan Y., Lynch J.J., Lyle E.A.;
RT   "Structure-based design of novel groups for use in the P1 position of
RT   thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles.";
RL   Bioorg. Med. Chem. Lett. 18:2062-2066(2008).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF 315-622 IN COMPLEX WITH
RP   SERPINA5 AND HEPARIN.
RX   PubMed=18362344; DOI=10.1073/pnas.0711055105;
RA   Li W., Adams T.E., Nangalia J., Esmon C.T., Huntington J.A.;
RT   "Molecular basis of thrombin recognition by protein C inhibitor
RT   revealed by the 1.6-A structure of the heparin-bridged complex.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:4661-4666(2008).
RN   [38]
RP   VARIANT FA2D LYS-200, AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=6405779; DOI=10.1111/j.1365-2141.1983.tb02092.x;
RA   Board P.G., Shaw D.C.;
RT   "Determination of the amino acid substitution in human prothrombin
RT   type 3 (157 Glu leads to Lys) and the localization of a third thrombin
RT   cleavage site.";
RL   Br. J. Haematol. 54:245-254(1983).
RN   [39]
RP   VARIANT FA2D CYS-314, AND PROTEIN SEQUENCE OF 310-327.
RX   PubMed=3771562;
RA   Rabiet M.-J., Furie B.C., Furie B.;
RT   "Molecular defect of prothrombin Barcelona. Substitution of cysteine
RT   for arginine at residue 273.";
RL   J. Biol. Chem. 261:15045-15048(1986).
RN   [40]
RP   VARIANT FA2D TRP-461, AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=3567158; DOI=10.1021/bi00378a020;
RA   Miyata T., Morita T., Inomoto T., Kawauchi S., Shirakami A.,
RA   Iwanaga S.;
RT   "Prothrombin Tokushima, a replacement of arginine-418 by tryptophan
RT   that impairs the fibrinogen clotting activity of derived thrombin
RT   Tokushima.";
RL   Biochemistry 26:1117-1122(1987).
RN   [41]
RP   VARIANT FA2D TRP-461.
RX   PubMed=3801671;
RA   Inomoto T., Shirakami A., Kawauchi S., Shigekiyo T., Saito S.,
RA   Miyoshi K., Morita T., Iwanaga S.;
RT   "Prothrombin Tokushima: characterization of dysfunctional thrombin
RT   derived from a variant of human prothrombin.";
RL   Blood 69:565-569(1987).
RN   [42]
RP   VARIANT FA2D CYS-425, AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=3242619; DOI=10.1021/bi00426a013;
RA   Henriksen R.A., Mann K.G.;
RT   "Identification of the primary structural defect in the dysthrombin
RT   thrombin Quick I: substitution of cysteine for arginine-382.";
RL   Biochemistry 27:9160-9165(1988).
RN   [43]
RP   VARIANT FA2D VAL-601, AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=2719946; DOI=10.1021/bi00431a017;
RA   Henriksen R.A., Mann K.G.;
RT   "Substitution of valine for glycine-558 in the congenital dysthrombin
RT   thrombin Quick II alters primary substrate specificity.";
RL   Biochemistry 28:2078-2082(1989).
RN   [44]
RP   VARIANT FA2D ALA-509, AND PARTIAL PROTEIN SEQUENCE.
RX   PubMed=1354985; DOI=10.1021/bi00148a005;
RA   Miyata T., Aruga R., Umeyama H., Bezeaud A., Guillin M.-C.,
RA   Iwanaga S.;
RT   "Prothrombin Salakta: substitution of glutamic acid-466 by alanine
RT   reduces the fibrinogen clotting activity and the esterase activity.";
RL   Biochemistry 31:7457-7462(1992).
RN   [45]
RP   VARIANTS FA2D THR-380 AND HIS-431.
RX   PubMed=1421398;
RA   Morishita E., Saito M., Kumabashiri I., Asakura H., Matsuda T.,
RA   Yamaguchi K.;
RT   "Prothrombin Himi: a compound heterozygote for two dysfunctional
RT   prothrombin molecules (Met-337-->Thr and Arg-388-->His).";
RL   Blood 80:2275-2280(1992).
RN   [46]
RP   VARIANT FA2D TRP-461.
RX   PubMed=1349838;
RA   Iwahana H., Yoshimoto K., Shigekiyo T., Shirakami A., Saito S.,
RA   Itakura M.;
RT   "Detection of a single base substitution of the gene for prothrombin
RT   Tokushima. The application of PCR-SSCP for the genetic and molecular
RT   analysis of dysprothrombinemia.";
RL   Int. J. Hematol. 55:93-100(1992).
RN   [47]
RP   VARIANT FA2D HIS-314.
RX   PubMed=7865694;
RA   James H.L., Kim D.J., Zheng D.-Q., Girolami A.;
RT   "Prothrombin Padua I: incomplete activation due to an amino acid
RT   substitution at a factor Xa cleavage site.";
RL   Blood Coagul. Fibrinolysis 5:841-844(1994).
RN   [48]
RP   VARIANT FA2D ALA-509.
RX   PubMed=7792730;
RA   Degen S.J.F., McDowell S.A., Sparks L.M., Scharrer I.;
RT   "Prothrombin Frankfurt: a dysfunctional prothrombin characterized by
RT   substitution of Glu-466 by Ala.";
RL   Thromb. Haemost. 73:203-209(1995).
RN   [49]
RP   VARIANTS MET-165 AND THR-386.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions
RT   of human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [50]
RP   ERRATUM.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
RN   [51]
RP   VARIANTS MET-165; LYS-200; THR-386 AND GLN-532, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=22028381; DOI=10.1093/jmcb/mjr024;
RA   Su Z.D., Sun L., Yu D.X., Li R.X., Li H.X., Yu Z.J., Sheng Q.H.,
RA   Lin X., Zeng R., Wu J.R.;
RT   "Quantitative detection of single amino acid polymorphisms by targeted
RT   proteomics.";
RL   J. Mol. Cell Biol. 3:309-315(2011).
CC   -!- FUNCTION: Thrombin, which cleaves bonds after Arg and Lys,
CC       converts fibrinogen to fibrin and activates factors V, VII, VIII,
CC       XIII, and, in complex with thrombomodulin, protein C. Functions in
CC       blood homeostasis, inflammation and wound healing.
CC       {ECO:0000269|PubMed:2856554}.
CC   -!- CATALYTIC ACTIVITY: Selective cleavage of Arg-|-Gly bonds in
CC       fibrinogen to form fibrin and release fibrinopeptides A and B.
CC   -!- ENZYME REGULATION: Inhibited by SERPINA5.
CC       {ECO:0000269|PubMed:6323392}.
CC   -!- SUBUNIT: Heterodimer (named alpha-thrombin) of a light and a heavy
CC       chain; disulfide-linked. Forms a heterodimer with SERPINA5.
CC       {ECO:0000269|PubMed:11493008, ECO:0000269|PubMed:16763681,
CC       ECO:0000269|PubMed:17685615, ECO:0000269|PubMed:18291642,
CC       ECO:0000269|PubMed:18362344, ECO:0000269|PubMed:2369893,
CC       ECO:0000269|PubMed:2374926}.
CC   -!- INTERACTION:
CC       Q846V4:- (xeno); NbExp=5; IntAct=EBI-297094, EBI-989571;
CC       P07204:THBD; NbExp=4; IntAct=EBI-297094, EBI-941422;
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space.
CC   -!- TISSUE SPECIFICITY: Expressed by the liver and secreted in plasma.
CC   -!- PTM: The gamma-carboxyglutamyl residues, which bind calcium ions,
CC       result from the carboxylation of glutamyl residues by a microsomal
CC       enzyme, the vitamin K-dependent carboxylase. The modified residues
CC       are necessary for the calcium-dependent interaction with a
CC       negatively charged phospholipid surface, which is essential for
CC       the conversion of prothrombin to thrombin.
CC       {ECO:0000269|PubMed:3759958, ECO:0000269|PubMed:6305407}.
CC   -!- PTM: N-glycosylated. N-glycan heterogeneity at Asn-121:
CC       Hex3HexNAc3 (minor), Hex4HexNAc3 (minor) and Hex5HexNAc4 (major).
CC       At Asn-143: Hex4HexNAc3 (minor) and Hex5HexNAc4 (major).
CC       {ECO:0000269|PubMed:14760718, ECO:0000269|PubMed:16335952,
CC       ECO:0000269|PubMed:19139490, ECO:0000269|PubMed:19159218,
CC       ECO:0000269|PubMed:19838169, ECO:0000269|PubMed:22171320,
CC       ECO:0000269|PubMed:873923}.
CC   -!- DISEASE: Factor II deficiency (FA2D) [MIM:613679]: A very rare
CC       blood coagulation disorder characterized by mucocutaneous bleeding
CC       symptoms. The severity of the bleeding manifestations correlates
CC       with blood factor II levels. {ECO:0000269|PubMed:1349838,
CC       ECO:0000269|PubMed:1354985, ECO:0000269|PubMed:1421398,
CC       ECO:0000269|PubMed:14962227, ECO:0000269|PubMed:2719946,
CC       ECO:0000269|PubMed:3242619, ECO:0000269|PubMed:3567158,
CC       ECO:0000269|PubMed:3771562, ECO:0000269|PubMed:3801671,
CC       ECO:0000269|PubMed:6405779, ECO:0000269|PubMed:7792730,
CC       ECO:0000269|PubMed:7865694}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Ischemic stroke (ISCHSTR) [MIM:601367]: A stroke is an
CC       acute neurologic event leading to death of neural tissue of the
CC       brain and resulting in loss of motor, sensory and/or cognitive
CC       function. Ischemic strokes, resulting from vascular occlusion, is
CC       considered to be a highly complex disease consisting of a group of
CC       heterogeneous disorders with multiple genetic and environmental
CC       risk factors. {ECO:0000269|PubMed:15534175}. Note=Disease
CC       susceptibility is associated with variations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Thrombophilia due to thrombin defect (THPH1)
CC       [MIM:188050]: A multifactorial disorder of hemostasis
CC       characterized by abnormal platelet aggregation in response to
CC       various agents and recurrent thrombi formation.
CC       {ECO:0000269|PubMed:2825773}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry. A common
CC       genetic variation in the 3-prime untranslated region of the
CC       prothrombin gene is associated with elevated plasma prothrombin
CC       levels and an increased risk of venous thrombosis.
CC   -!- DISEASE: Pregnancy loss, recurrent, 2 (RPRGL2) [MIM:614390]: A
CC       common complication of pregnancy, resulting in spontaneous
CC       abortion before the fetus has reached viability. The term includes
CC       all miscarriages from the time of conception until 24 weeks of
CC       gestation. Recurrent pregnancy loss is defined as 3 or more
CC       consecutive spontaneous abortions. {ECO:0000269|PubMed:11506076}.
CC       Note=Disease susceptibility is associated with variations
CC       affecting the gene represented in this entry.
CC   -!- PHARMACEUTICAL: The peptide TP508 also known as Chrysalin
CC       (Orthologic) could be used to accelerate repair of both soft and
CC       hard tissues.
CC   -!- MISCELLANEOUS: Prothrombin is activated on the surface of a
CC       phospholipid membrane that binds the amino end of prothrombin and
CC       factors Va and Xa in Ca-dependent interactions; factor Xa removes
CC       the activation peptide and cleaves the remaining part into light
CC       and heavy chains. The activation process starts slowly because
CC       factor V itself has to be activated by the initial, small amounts
CC       of thrombin.
CC   -!- MISCELLANEOUS: It is not known whether 1 or 2 smaller activation
CC       peptides, with additional cleavage after Arg-314, are released in
CC       natural blood clotting.
CC   -!- MISCELLANEOUS: Thrombin can itself cleave the N-terminal fragment
CC       (fragment 1) of the prothrombin, prior to its activation by factor
CC       Xa.
CC   -!- MISCELLANEOUS: The cleavage after Arg-198, observed in vitro, does
CC       not occur in plasma.
CC   -!- SIMILARITY: Belongs to the peptidase S1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00274}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Thrombin entry;
CC       URL="https://en.wikipedia.org/wiki/Thrombin";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/f2/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M17262; AAC63054.1; -; Genomic_DNA.
DR   EMBL; AJ972449; CAJ01369.1; -; mRNA.
DR   EMBL; AK303747; BAG64719.1; -; mRNA.
DR   EMBL; AK312965; BAG35804.1; -; mRNA.
DR   EMBL; AK222775; BAD96495.1; -; mRNA.
DR   EMBL; AK222777; BAD96497.1; -; mRNA.
DR   EMBL; AF478696; AAL77436.1; -; Genomic_DNA.
DR   EMBL; BC051332; AAH51332.1; -; mRNA.
DR   EMBL; V00595; CAA23842.1; -; mRNA.
DR   EMBL; AY344794; AAR08143.1; -; mRNA.
DR   CCDS; CCDS31476.1; -.
DR   PIR; A29351; TBHU.
DR   RefSeq; NP_000497.1; NM_000506.4.
DR   RefSeq; NP_001298186.1; NM_001311257.1.
DR   UniGene; Hs.655207; -.
DR   PDB; 1A2C; X-ray; 2.10 A; H=364-622, L=328-363.
DR   PDB; 1A3B; X-ray; 1.80 A; H=364-622, L=328-363.
DR   PDB; 1A3E; X-ray; 1.85 A; H=364-622, L=328-363.
DR   PDB; 1A46; X-ray; 2.12 A; H=364-622, L=328-363.
DR   PDB; 1A4W; X-ray; 1.80 A; H=364-622, L=328-363.
DR   PDB; 1A5G; X-ray; 2.06 A; H=364-622, L=328-363.
DR   PDB; 1A61; X-ray; 2.20 A; H=364-622, L=328-363.
DR   PDB; 1ABI; X-ray; 2.30 A; H=364-622, L=328-363.
DR   PDB; 1ABJ; X-ray; 2.40 A; H=364-622, L=328-363.
DR   PDB; 1AD8; X-ray; 2.00 A; H=364-622, L=328-363.
DR   PDB; 1AE8; X-ray; 2.00 A; H=364-622, L=328-363.
DR   PDB; 1AFE; X-ray; 2.00 A; H=364-622, L=328-363.
DR   PDB; 1AHT; X-ray; 1.60 A; H=364-622, L=328-363.
DR   PDB; 1AI8; X-ray; 1.85 A; H=364-622, L=328-363.
DR   PDB; 1AIX; X-ray; 2.10 A; H=364-622, L=328-363.
DR   PDB; 1AWF; X-ray; 2.20 A; H=364-622, L=328-363.
DR   PDB; 1AWH; X-ray; 3.00 A; A/C=328-363, B/D=364-622.
DR   PDB; 1AY6; X-ray; 1.80 A; H=364-622, L=328-363.
DR   PDB; 1B5G; X-ray; 2.07 A; H=364-622, L=328-363.
DR   PDB; 1B7X; X-ray; 2.10 A; A=328-363, B=364-622.
DR   PDB; 1BA8; X-ray; 1.80 A; A=328-363, B=364-622.
DR   PDB; 1BB0; X-ray; 2.10 A; A=328-363, B=364-622.
DR   PDB; 1BCU; X-ray; 2.00 A; H=364-622, L=328-363.
DR   PDB; 1BHX; X-ray; 2.30 A; A=331-349, B=364-510, F=518-622.
DR   PDB; 1BMM; X-ray; 2.60 A; H=364-622, L=328-363.
DR   PDB; 1BMN; X-ray; 2.80 A; H=364-622, L=328-363.
DR   PDB; 1BTH; X-ray; 2.30 A; H/K=364-622, J/L=328-363.
DR   PDB; 1C1U; X-ray; 1.75 A; H=364-616, L=328-363.
DR   PDB; 1C1V; X-ray; 1.98 A; H=364-616, L=328-363.
DR   PDB; 1C1W; X-ray; 1.90 A; H=364-616, L=328-363.
DR   PDB; 1C4U; X-ray; 2.10 A; 1=328-363, 2=364-622.
DR   PDB; 1C4V; X-ray; 2.10 A; 1=328-363, 2=364-622.
DR   PDB; 1C4Y; X-ray; 2.70 A; 1=328-363, 2=364-622.
DR   PDB; 1C5L; X-ray; 1.47 A; H=364-622, L=328-363.
DR   PDB; 1C5N; X-ray; 1.50 A; H=364-622, L=328-363.
DR   PDB; 1C5O; X-ray; 1.90 A; H=364-622, L=328-363.
DR   PDB; 1CA8; X-ray; 2.10 A; A=328-363, B=364-622.
DR   PDB; 1D3D; X-ray; 2.04 A; A=333-360, B=364-620.
DR   PDB; 1D3P; X-ray; 2.10 A; A=328-363, B=364-622.
DR   PDB; 1D3Q; X-ray; 2.90 A; A=328-363, B=364-622.
DR   PDB; 1D3T; X-ray; 3.00 A; A=328-363, B=364-622.
DR   PDB; 1D4P; X-ray; 2.07 A; A=328-363, B=364-622.
DR   PDB; 1D6W; X-ray; 2.00 A; A=334-620.
DR   PDB; 1D9I; X-ray; 2.30 A; A=334-621.
DR   PDB; 1DE7; X-ray; 2.00 A; H/K=364-619, J/L=328-360.
DR   PDB; 1DIT; X-ray; 2.30 A; H=364-622, L=328-363.
DR   PDB; 1DM4; X-ray; 2.50 A; A=328-362, B=363-622.
DR   PDB; 1DOJ; X-ray; 1.70 A; A=328-622.
DR   PDB; 1DWB; X-ray; 3.16 A; H=364-622, L=328-363.
DR   PDB; 1DWC; X-ray; 3.00 A; H=364-622, L=328-363.
DR   PDB; 1DWD; X-ray; 3.00 A; H=364-622, L=328-363.
DR   PDB; 1DWE; X-ray; 3.00 A; H=364-622, L=328-363.
DR   PDB; 1DX5; X-ray; 2.30 A; A/B/C/D=328-363, M/N/O/P=364-622.
DR   PDB; 1E0F; X-ray; 3.10 A; A/B/C=328-363, D/E/F=364-622.
DR   PDB; 1EB1; X-ray; 1.80 A; H=364-620, L=334-360.
DR   PDB; 1EOJ; X-ray; 2.10 A; A=332-620.
DR   PDB; 1EOL; X-ray; 2.10 A; A=332-620.
DR   PDB; 1FPC; X-ray; 2.30 A; H=364-622, L=328-363.
DR   PDB; 1FPH; X-ray; 2.50 A; H=364-622, L=328-363.
DR   PDB; 1G30; X-ray; 2.00 A; A=328-363, B=364-622.
DR   PDB; 1G32; X-ray; 1.90 A; A=328-363, B=364-622.
DR   PDB; 1G37; X-ray; 2.00 A; A=334-620.
DR   PDB; 1GHV; X-ray; 1.85 A; H=364-620, L=328-363.
DR   PDB; 1GHW; X-ray; 1.75 A; H=364-620, L=328-363.
DR   PDB; 1GHX; X-ray; 1.65 A; H=364-620, L=328-363.
DR   PDB; 1GHY; X-ray; 1.85 A; H=364-620, L=328-363.
DR   PDB; 1GJ4; X-ray; 1.81 A; H=364-621, L=328-363.
DR   PDB; 1GJ5; X-ray; 1.73 A; H=364-621, L=328-363.
DR   PDB; 1H8D; X-ray; 1.40 A; H=364-621, L=333-360.
DR   PDB; 1H8I; X-ray; 1.75 A; H=364-622, L=334-360.
DR   PDB; 1HAG; X-ray; 2.00 A; E=328-622.
DR   PDB; 1HAH; X-ray; 2.30 A; H=364-622, L=328-363.
DR   PDB; 1HAI; X-ray; 2.40 A; H=364-622, L=328-363.
DR   PDB; 1HAO; X-ray; 2.80 A; H=364-622, L=328-363.
DR   PDB; 1HAP; X-ray; 2.80 A; H=364-622, L=328-360.
DR   PDB; 1HBT; X-ray; 2.00 A; H=364-622, L=328-363.
DR   PDB; 1HDT; X-ray; 2.60 A; H=364-622, L=331-363.
DR   PDB; 1HGT; X-ray; 2.20 A; H=364-622, L=328-363.
DR   PDB; 1HLT; X-ray; 3.00 A; H/K=364-622, J/L=334-349.
DR   PDB; 1HUT; X-ray; 2.90 A; H=364-622, L=328-363.
DR   PDB; 1HXE; X-ray; 2.10 A; H=364-622, L=328-363.
DR   PDB; 1HXF; X-ray; 2.10 A; H=364-622, L=328-363.
DR   PDB; 1IHS; X-ray; 2.00 A; H=364-622, L=328-363.
DR   PDB; 1IHT; X-ray; 2.10 A; H=364-622, L=328-363.
DR   PDB; 1JMO; X-ray; 2.20 A; H=363-622, L=315-362.
DR   PDB; 1JOU; X-ray; 1.80 A; A/C/E=315-363, B/D/F=364-622.
DR   PDB; 1JWT; X-ray; 2.50 A; A=328-622.
DR   PDB; 1K21; X-ray; 1.86 A; H=364-622, L=328-363.
DR   PDB; 1K22; X-ray; 1.93 A; H=364-622, L=328-363.
DR   PDB; 1KTS; X-ray; 2.40 A; A=328-363, B=364-622.
DR   PDB; 1KTT; X-ray; 2.10 A; A=328-363, B=364-622.
DR   PDB; 1LHC; X-ray; 1.95 A; H=364-622, L=328-363.
DR   PDB; 1LHD; X-ray; 2.35 A; H=364-622, L=328-363.
DR   PDB; 1LHE; X-ray; 2.25 A; H=364-622, L=328-363.
DR   PDB; 1LHF; X-ray; 2.40 A; H=364-622, L=328-363.
DR   PDB; 1LHG; X-ray; 2.25 A; H=364-622, L=328-363.
DR   PDB; 1MH0; X-ray; 2.80 A; A/B=334-620.
DR   PDB; 1MU6; X-ray; 1.99 A; A=328-363, B=364-622.
DR   PDB; 1MU8; X-ray; 2.00 A; A=328-363, B=364-622.
DR   PDB; 1MUE; X-ray; 2.00 A; A=328-363, B=364-622.
DR   PDB; 1NM6; X-ray; 1.80 A; A=335-621.
DR   PDB; 1NO9; X-ray; 1.90 A; H=364-622, L=328-363.
DR   PDB; 1NRN; X-ray; 3.10 A; H=364-622, L=328-363.
DR   PDB; 1NRO; X-ray; 3.10 A; H=364-622, L=328-363.
DR   PDB; 1NRP; X-ray; 3.00 A; H=364-622, L=328-363.
DR   PDB; 1NRQ; X-ray; 3.50 A; H=364-622, L=328-363.
DR   PDB; 1NRR; X-ray; 2.40 A; H=364-622, L=328-363.
DR   PDB; 1NRS; X-ray; 2.40 A; H=364-622, L=328-349.
DR   PDB; 1NT1; X-ray; 2.00 A; A=335-621.
DR   PDB; 1NU7; X-ray; 2.20 A; A/E=332-359, B/F=364-622.
DR   PDB; 1NU9; X-ray; 2.20 A; A/D=332-622.
DR   PDB; 1NY2; X-ray; 2.30 A; 1=328-363, 2=364-622.
DR   PDB; 1NZQ; X-ray; 2.18 A; H=364-620, L=328-361.
DR   PDB; 1O0D; X-ray; 2.44 A; H=364-622, L=328-363.
DR   PDB; 1O2G; X-ray; 1.58 A; H=364-622, L=328-363.
DR   PDB; 1O5G; X-ray; 1.75 A; H=364-622, L=328-363.
DR   PDB; 1OOK; X-ray; 2.30 A; A=328-363, B=364-622.
DR   PDB; 1OYT; X-ray; 1.67 A; H=364-622, L=328-363.
DR   PDB; 1P8V; X-ray; 2.60 A; B=333-361, C=364-621.
DR   PDB; 1PPB; X-ray; 1.92 A; H=364-622, L=328-363.
DR   PDB; 1QBV; X-ray; 1.80 A; H=364-622, L=328-359.
DR   PDB; 1QHR; X-ray; 2.20 A; A=328-363, B=364-622.
DR   PDB; 1QJ1; X-ray; 2.00 A; A=328-363, B=364-622.
DR   PDB; 1QJ6; X-ray; 2.20 A; A=328-363, B=364-622.
DR   PDB; 1QJ7; X-ray; 2.20 A; A=328-363, B=364-622.
DR   PDB; 1QUR; X-ray; 2.00 A; H=364-620, L=334-360.
DR   PDB; 1RD3; X-ray; 2.50 A; A/C=328-363, B/D=364-622.
DR   PDB; 1RIW; X-ray; 2.04 A; A=328-363, B=364-510, C=518-622.
DR   PDB; 1SB1; X-ray; 1.90 A; H=364-621, L=333-361.
DR   PDB; 1SFQ; X-ray; 1.91 A; A/D=328-363, B/E=364-622.
DR   PDB; 1SG8; X-ray; 2.30 A; A/D=328-363, B/E=364-622.
DR   PDB; 1SGI; X-ray; 2.30 A; A/D=328-363, B/E=364-622.
DR   PDB; 1SHH; X-ray; 1.55 A; A/D=328-363, B/E=364-622.
DR   PDB; 1SL3; X-ray; 1.81 A; A=335-621.
DR   PDB; 1SR5; X-ray; 3.10 A; B=328-363, C=364-622.
DR   PDB; 1T4U; X-ray; 2.00 A; H=364-622, L=334-359.
DR   PDB; 1T4V; X-ray; 2.00 A; H=364-622, L=334-359.
DR   PDB; 1TA2; X-ray; 2.30 A; A=335-621.
DR   PDB; 1TA6; X-ray; 1.90 A; A=335-621.
DR   PDB; 1TB6; X-ray; 2.50 A; H=364-622, L=315-363.
DR   PDB; 1TBZ; X-ray; 2.30 A; H=364-622, L=328-363.
DR   PDB; 1THP; X-ray; 2.10 A; A=328-362, B=364-620.
DR   PDB; 1THR; X-ray; 2.30 A; H=364-622, L=328-349.
DR   PDB; 1THS; X-ray; 2.20 A; H=364-622, L=328-363.
DR   PDB; 1TMB; X-ray; 2.30 A; H=364-622, L=328-363.
DR   PDB; 1TMT; X-ray; 2.20 A; H=364-622, L=328-363.
DR   PDB; 1TMU; X-ray; 2.50 A; H=364-620, L=333-349.
DR   PDB; 1TOM; X-ray; 1.80 A; H=364-622, L=328-363.
DR   PDB; 1TQ0; X-ray; 2.80 A; A/C=333-363, B/D=364-620.
DR   PDB; 1TQ7; X-ray; 2.40 A; A=320-363, B=364-620.
DR   PDB; 1TWX; X-ray; 2.40 A; A=334-349, B=364-622.
DR   PDB; 1UMA; X-ray; 2.00 A; H=364-622, L=328-363.
DR   PDB; 1UVS; X-ray; 2.80 A; H=364-622, L=328-363.
DR   PDB; 1VR1; X-ray; 1.90 A; H=364-620, L=334-360.
DR   PDB; 1VZQ; X-ray; 1.54 A; H=364-620, L=334-360.
DR   PDB; 1W7G; X-ray; 1.65 A; H=364-622, L=328-363.
DR   PDB; 1WAY; X-ray; 2.02 A; A=328-363, B=364-622.
DR   PDB; 1WBG; X-ray; 2.20 A; A=328-363, B=364-622.
DR   PDB; 1XM1; X-ray; 2.30 A; A=328-622.
DR   PDB; 1XMN; X-ray; 1.85 A; A/C/E/G=328-363, B/D/F/H=364-622.
DR   PDB; 1YPE; X-ray; 1.81 A; H=364-620, L=334-360.
DR   PDB; 1YPG; X-ray; 1.80 A; H=364-620, L=334-360.
DR   PDB; 1YPJ; X-ray; 1.78 A; H=364-620, L=334-360.
DR   PDB; 1YPK; X-ray; 1.78 A; H=364-620, L=334-360.
DR   PDB; 1YPL; X-ray; 1.85 A; H=364-620, L=334-360.
DR   PDB; 1YPM; X-ray; 1.85 A; H=364-620, L=334-360.
DR   PDB; 1Z71; X-ray; 1.80 A; A=335-621.
DR   PDB; 1Z8I; X-ray; 2.00 A; A=324-361, B=364-622.
DR   PDB; 1Z8J; X-ray; 2.00 A; A=322-361, B=364-622.
DR   PDB; 1ZGI; X-ray; 2.20 A; A=335-621.
DR   PDB; 1ZGV; X-ray; 2.20 A; A=335-621.
DR   PDB; 1ZRB; X-ray; 1.90 A; A=335-621.
DR   PDB; 2A0Q; X-ray; 1.90 A; A/C=334-349, B/D=364-620.
DR   PDB; 2A2X; X-ray; 2.44 A; H=364-622, L=330-363.
DR   PDB; 2A45; X-ray; 3.65 A; A/D=328-363, B/E=364-622.
DR   PDB; 2AFQ; X-ray; 1.93 A; A/C=332-360, B/D=364-622.
DR   PDB; 2ANK; X-ray; 2.46 A; H=364-622, L=330-363.
DR   PDB; 2ANM; X-ray; 2.40 A; H=364-620, L=328-363.
DR   PDB; 2B5T; X-ray; 2.10 A; A/C=315-363, B/D=364-622.
DR   PDB; 2BDY; X-ray; 1.61 A; A=334-622.
DR   PDB; 2BVR; X-ray; 1.25 A; H=364-622, L=328-363.
DR   PDB; 2BVS; X-ray; 1.40 A; H=364-622, L=328-363.
DR   PDB; 2BVX; X-ray; 3.20 A; H=364-622, L=328-363.
DR   PDB; 2BXT; X-ray; 1.83 A; H=364-622, L=328-363.
DR   PDB; 2BXU; X-ray; 2.80 A; H=364-622, L=328-363.
DR   PDB; 2C8W; X-ray; 1.96 A; A=328-363, B=364-622.
DR   PDB; 2C8X; X-ray; 2.17 A; A=328-363, B=364-622.
DR   PDB; 2C8Y; X-ray; 2.20 A; A=328-363, B=364-622.
DR   PDB; 2C8Z; X-ray; 2.14 A; A=328-363, B=364-622.
DR   PDB; 2C90; X-ray; 2.25 A; A=328-363, B=364-622.
DR   PDB; 2C93; X-ray; 2.20 A; A=328-363, B=364-622.
DR   PDB; 2CF8; X-ray; 1.30 A; H=364-620, L=334-361.
DR   PDB; 2CF9; X-ray; 1.79 A; H=364-620, L=334-361.
DR   PDB; 2CN0; X-ray; 1.30 A; H=364-620, L=334-361.
DR   PDB; 2FEQ; X-ray; 2.44 A; H=364-622, L=328-363.
DR   PDB; 2FES; X-ray; 2.42 A; H=364-622, L=328-363.
DR   PDB; 2GDE; X-ray; 2.00 A; H=364-622, L=328-363.
DR   PDB; 2GP9; X-ray; 1.87 A; A=328-362, B=364-620.
DR   PDB; 2H9T; X-ray; 2.40 A; H=364-622, L=328-363.
DR   PDB; 2HGT; X-ray; 2.20 A; H=364-622, L=328-363.
DR   PDB; 2HNT; X-ray; 2.50 A; C=364-433, E=437-517, F=518-622, L=328-363.
DR   PDB; 2HPP; X-ray; 3.30 A; H=364-622, L=328-363.
DR   PDB; 2HPQ; X-ray; 3.30 A; H=364-622, L=328-363, P=213-291.
DR   PDB; 2HWL; X-ray; 2.40 A; A/C=328-363, B/D=364-622.
DR   PDB; 2JH0; X-ray; 1.70 A; C=328-361, D=364-622.
DR   PDB; 2JH5; X-ray; 2.50 A; C=328-363, D=364-622.
DR   PDB; 2JH6; X-ray; 2.21 A; C=328-361, D=364-622.
DR   PDB; 2OD3; X-ray; 1.75 A; A=328-363, B=364-622.
DR   PDB; 2PGB; X-ray; 1.54 A; A=328-363, B=364-622.
DR   PDB; 2PGQ; X-ray; 1.80 A; A=319-363, B=364-622.
DR   PDB; 2PKS; X-ray; 2.50 A; A=334-360, B=364-510, C=518-619.
DR   PDB; 2PW8; X-ray; 1.84 A; H=364-621, L=334-360.
DR   PDB; 2R2M; X-ray; 2.10 A; A=334-359, B=364-622.
DR   PDB; 2THF; X-ray; 2.10 A; A=328-363, B=364-622.
DR   PDB; 2UUF; X-ray; 1.26 A; A=328-363, B=364-622.
DR   PDB; 2UUJ; X-ray; 1.32 A; A=328-363, B=364-622.
DR   PDB; 2UUK; X-ray; 1.39 A; A=328-363, B=364-622.
DR   PDB; 2V3H; X-ray; 1.79 A; H=364-620, L=334-361.
DR   PDB; 2V3O; X-ray; 1.79 A; H=364-620, L=334-361.
DR   PDB; 2ZC9; X-ray; 1.58 A; H=364-622, L=328-363.
DR   PDB; 2ZDA; X-ray; 1.73 A; H=364-622, L=328-363.
DR   PDB; 2ZDV; X-ray; 1.72 A; H=364-622, L=328-363.
DR   PDB; 2ZF0; X-ray; 2.20 A; H=364-622, L=328-363.
DR   PDB; 2ZFF; X-ray; 1.47 A; H=364-622, L=328-363.
DR   PDB; 2ZFP; X-ray; 2.25 A; H=364-622, L=328-363.
DR   PDB; 2ZFQ; X-ray; 1.80 A; H=364-622, L=328-363.
DR   PDB; 2ZFR; X-ray; 1.85 A; H=364-622, L=328-363.
DR   PDB; 2ZG0; X-ray; 1.75 A; H=364-622, L=328-363.
DR   PDB; 2ZGB; X-ray; 1.60 A; H=364-622, L=328-363.
DR   PDB; 2ZGX; X-ray; 1.80 A; H=364-622, L=328-363.
DR   PDB; 2ZHE; X-ray; 2.10 A; H=364-622, L=328-363.
DR   PDB; 2ZHF; X-ray; 1.98 A; H=364-622, L=328-363.
DR   PDB; 2ZHQ; X-ray; 1.96 A; H=364-622, L=328-363.
DR   PDB; 2ZHW; X-ray; 2.02 A; H=364-622, L=328-363.
DR   PDB; 2ZI2; X-ray; 1.65 A; H=364-622, L=328-363.
DR   PDB; 2ZIQ; X-ray; 1.65 A; H=364-622, L=328-363.
DR   PDB; 2ZNK; X-ray; 1.80 A; H=364-622, L=328-363.
DR   PDB; 2ZO3; X-ray; 1.70 A; H=364-622, L=328-363.
DR   PDB; 3B23; X-ray; 2.40 A; A=328-363, B=364-622.
DR   PDB; 3B9F; X-ray; 1.60 A; H=364-622, L=315-363.
DR   PDB; 3BEF; X-ray; 2.20 A; A/D=320-363, B/E=364-622.
DR   PDB; 3BEI; X-ray; 1.55 A; A=320-363, B=364-622.
DR   PDB; 3BF6; X-ray; 2.50 A; H=364-622, L=328-363.
DR   PDB; 3BIU; X-ray; 2.30 A; H=364-620, L=333-361.
DR   PDB; 3BIV; X-ray; 1.80 A; H=364-620, L=333-361.
DR   PDB; 3BV9; X-ray; 1.80 A; A=333-363, B=364-622.
DR   PDB; 3C1K; X-ray; 1.84 A; A=335-621.
DR   PDB; 3C27; X-ray; 2.18 A; A=334-359, B=364-622.
DR   PDB; 3D49; X-ray; 1.50 A; H=364-622, L=328-363.
DR   PDB; 3DA9; X-ray; 1.80 A; A=328-363, B=364-622.
DR   PDB; 3DD2; X-ray; 1.90 A; H=364-621, L=332-361.
DR   PDB; 3DHK; X-ray; 1.73 A; H=364-622, L=328-363.
DR   PDB; 3DT0; X-ray; 2.40 A; H=364-622, L=328-363.
DR   PDB; 3DUX; X-ray; 1.60 A; H=364-622, L=328-363.
DR   PDB; 3E6P; X-ray; 2.10 A; H=364-622, L=206-363.
DR   PDB; 3EE0; X-ray; 2.75 A; A=328-363, B=364-622.
DR   PDB; 3EGK; X-ray; 2.20 A; H=364-622, L=328-363.
DR   PDB; 3EQ0; X-ray; 1.53 A; H=364-622, L=328-363.
DR   PDB; 3F68; X-ray; 1.75 A; H=364-622, L=328-363.
DR   PDB; 3GIC; X-ray; 1.55 A; A=328-363, B=364-622.
DR   PDB; 3GIS; X-ray; 2.40 A; A/C/E=315-363, B/D/F=364-622.
DR   PDB; 3HAT; X-ray; 2.50 A; H=364-622, L=328-363.
DR   PDB; 3HKJ; X-ray; 2.60 A; A/D=333-363, B/E=364-622.
DR   PDB; 3HTC; X-ray; 2.30 A; H=364-622, L=328-363.
DR   PDB; 3JZ1; X-ray; 1.60 A; A=328-363, B=364-622.
DR   PDB; 3JZ2; X-ray; 2.40 A; A=328-363, B=364-622.
DR   PDB; 3K65; X-ray; 1.85 A; A=199-314, B=315-622.
DR   PDB; 3LDX; X-ray; 2.25 A; H=364-622, L=328-363.
DR   PDB; 3LU9; X-ray; 1.80 A; A/D=318-363, B/E=364-622.
DR   PDB; 3NXP; X-ray; 2.20 A; A=199-622.
DR   PDB; 3P17; X-ray; 1.43 A; H=364-622, L=328-363.
DR   PDB; 3P6Z; X-ray; 1.70 A; A/G=328-363, B/H=364-622.
DR   PDB; 3P70; X-ray; 2.55 A; A/C/E/G=328-363, B/D/F/H=364-622.
DR   PDB; 3PMH; X-ray; 3.20 A; A=328-363, B=364-622.
DR   PDB; 3PO1; X-ray; 1.65 A; A=334-360, B=364-510, C=518-619.
DR   PDB; 3QDZ; X-ray; 2.80 A; A/C=333-363, B/D=364-622.
DR   PDB; 3QGN; X-ray; 2.10 A; A=333-363, B=364-622.
DR   PDB; 3QLP; X-ray; 2.14 A; H=364-622, L=328-363.
DR   PDB; 3QTO; X-ray; 1.52 A; H=364-622, L=328-363.
DR   PDB; 3QTV; X-ray; 1.63 A; H=364-622, L=328-363.
DR   PDB; 3QWC; X-ray; 1.75 A; H=364-622, L=328-363.
DR   PDB; 3QX5; X-ray; 1.35 A; H=364-622, L=328-363.
DR   PDB; 3R3G; X-ray; 1.75 A; A=333-363, B=364-622.
DR   PDB; 3RLW; X-ray; 1.69 A; H=364-622, L=328-363.
DR   PDB; 3RLY; X-ray; 1.51 A; H=364-622, L=328-363.
DR   PDB; 3RM0; X-ray; 1.34 A; H=364-622, L=328-363.
DR   PDB; 3RM2; X-ray; 1.23 A; H=364-622, L=328-363.
DR   PDB; 3RML; X-ray; 1.53 A; H=364-622, L=328-363.
DR   PDB; 3RMM; X-ray; 1.58 A; H=364-622, L=328-363.
DR   PDB; 3RMN; X-ray; 1.78 A; H=364-622, L=328-363.
DR   PDB; 3RMO; X-ray; 1.40 A; H=364-622, L=328-363.
DR   PDB; 3S7H; X-ray; 1.90 A; A=329-363, B=364-622.
DR   PDB; 3S7K; X-ray; 1.90 A; A/C=329-363, B/D=364-622.
DR   PDB; 3SHA; X-ray; 1.52 A; H=364-622, L=328-363.
DR   PDB; 3SHC; X-ray; 1.90 A; H=364-622, L=328-363.
DR   PDB; 3SI3; X-ray; 1.55 A; H=364-622, L=328-363.
DR   PDB; 3SI4; X-ray; 1.27 A; H=364-622, L=328-363.
DR   PDB; 3SQE; X-ray; 1.90 A; E=333-622.
DR   PDB; 3SQH; X-ray; 2.20 A; E=333-622.
DR   PDB; 3SV2; X-ray; 1.30 A; H=364-622, L=328-363.
DR   PDB; 3T5F; X-ray; 1.45 A; H=364-622, L=328-363.
DR   PDB; 3TU7; X-ray; 2.49 A; H=364-622, L=328-363.
DR   PDB; 3U69; X-ray; 1.55 A; H=364-622, L=334-363.
DR   PDB; 3U8O; X-ray; 1.28 A; H=364-622, L=334-363.
DR   PDB; 3U8R; X-ray; 1.47 A; H=364-622, L=334-363.
DR   PDB; 3U8T; X-ray; 1.86 A; H=364-620, L=334-360.
DR   PDB; 3U98; X-ray; 1.45 A; H=364-622, L=328-363.
DR   PDB; 3U9A; X-ray; 1.58 A; H=364-622, L=328-363.
DR   PDB; 3UTU; X-ray; 1.55 A; H=364-622, L=328-363.
DR   PDB; 3UWJ; X-ray; 1.50 A; H=364-622, L=328-363.
DR   PDB; 3VXE; X-ray; 1.25 A; H=364-622, L=328-363.
DR   PDB; 3VXF; Other; 1.60 A; H=364-622, L=328-363.
DR   PDB; 4AX9; X-ray; 1.90 A; H=364-620, L=334-361.
DR   PDB; 4AYV; X-ray; 2.80 A; A=332-361, B=364-620.
DR   PDB; 4AYY; X-ray; 2.60 A; A=332-361, B=364-620.
DR   PDB; 4AZ2; X-ray; 2.60 A; A=332-361, B=364-620.
DR   PDB; 4BAH; X-ray; 1.94 A; A=328-363, B=364-622.
DR   PDB; 4BAK; X-ray; 1.94 A; A=328-363, B=364-622.
DR   PDB; 4BAM; X-ray; 1.88 A; A=328-363, B=364-622.
DR   PDB; 4BAN; X-ray; 1.87 A; A=328-363, B=364-622.
DR   PDB; 4BAO; X-ray; 1.87 A; A=328-363, B=364-622.
DR   PDB; 4BAQ; X-ray; 1.89 A; A=328-363, B=364-622.
DR   PDB; 4BOH; X-ray; 2.60 A; A/H=364-622, B/L=328-363.
DR   PDB; 4CH2; X-ray; 1.60 A; A/C=328-363, B/D=364-622.
DR   PDB; 4CH8; X-ray; 1.75 A; A/C/E/G=328-363, B/D/F/H=364-622.
DR   PDB; 4DIH; X-ray; 1.80 A; H=364-622, L=328-363.
DR   PDB; 4DII; X-ray; 2.05 A; H=364-622, L=328-363.
DR   PDB; 4DT7; X-ray; 1.90 A; A/C=332-363, B/D=364-622.
DR   PDB; 4DY7; X-ray; 2.80 A; A/D=315-363, B/E=364-622.
DR   PDB; 4E05; X-ray; 2.30 A; H=364-622, L=328-363.
DR   PDB; 4E06; X-ray; 3.20 A; H=364-622, L=328-363.
DR   PDB; 4E7R; X-ray; 2.25 A; G/H=364-622, L/M=328-363.
DR   PDB; 4H6S; X-ray; 2.19 A; A=333-363, B=364-622.
DR   PDB; 4H6T; X-ray; 2.40 A; A=317-622.
DR   PDB; 4HFP; X-ray; 2.40 A; A/C=333-363, B/D=364-622.
DR   PDB; 4HTC; X-ray; 2.30 A; H=364-622, L=328-363.
DR   PDB; 4HZH; X-ray; 3.30 A; A/B=90-622.
DR   PDB; 4I7Y; X-ray; 2.40 A; H=364-622, L=328-363.
DR   PDB; 4LOY; X-ray; 1.77 A; H=364-620, L=334-360.
DR   PDB; 4LXB; X-ray; 1.61 A; H=364-622, L=328-363.
DR   PDB; 4LZ1; X-ray; 1.65 A; H=364-622, L=328-363.
DR   PDB; 4LZ4; X-ray; 2.56 A; A/C=328-363, B/D=364-622.
DR   PDB; 4MLF; X-ray; 2.20 A; A=331-363, B=364-622.
DR   PDB; 4N3L; X-ray; 1.94 A; H=364-622, L=328-363.
DR   PDB; 4NZE; X-ray; 1.98 A; H=364-622, L=328-363.
DR   PDB; 4NZQ; X-ray; 2.81 A; A=44-622.
DR   PDB; 4O03; X-ray; 3.38 A; A=44-622.
DR   PDB; 4RKJ; X-ray; 1.70 A; A=330-363, B=364-622.
DR   PDB; 4RKO; X-ray; 1.84 A; A=322-363, B=364-622.
DR   PDB; 4RN6; X-ray; 3.00 A; A/B=333-622.
DR   PDB; 4THN; X-ray; 2.50 A; H=364-622, L=328-363.
DR   PDB; 4UD9; X-ray; 1.12 A; H=364-622, L=333-360.
DR   PDB; 4UDW; X-ray; 1.16 A; H=364-621, L=333-360.
DR   PDB; 4UE7; X-ray; 1.13 A; H=364-621, L=333-360.
DR   PDB; 4UEH; X-ray; 1.16 A; H=364-621, L=333-361.
DR   PDB; 4UFD; X-ray; 1.43 A; H=364-621, L=333-360.
DR   PDB; 4UFE; X-ray; 1.59 A; H=364-621, L=333-361.
DR   PDB; 4UFF; X-ray; 1.55 A; H=364-621, L=333-361.
DR   PDB; 4UFG; X-ray; 1.65 A; H=364-621, L=333-361.
DR   PDB; 4YES; X-ray; 1.50 A; A=328-363, B=364-622.
DR   PDB; 5A2M; X-ray; 1.40 A; H=364-621, L=333-361.
DR   PDB; 5AF9; X-ray; 1.18 A; H=364-621, L=333-361.
DR   PDB; 5AFY; X-ray; 1.12 A; H=364-621, L=333-361.
DR   PDB; 5AFZ; X-ray; 1.53 A; H=364-621, L=333-361.
DR   PDB; 5AHG; X-ray; 1.24 A; H=364-621, L=333-361.
DR   PDB; 5CMX; X-ray; 2.98 A; H=364-622, L=328-363.
DR   PDB; 5DO4; X-ray; 1.86 A; H=364-621, L=328-363.
DR   PDB; 5E8E; X-ray; 1.90 A; H=364-622, L=328-363.
DR   PDB; 5EDK; X-ray; 3.21 A; A=44-622.
DR   PDB; 5EDM; X-ray; 2.20 A; A=44-622.
DR   PDB; 5EW1; X-ray; 2.95 A; H=364-622, L=328-363.
DR   PDB; 5EW2; X-ray; 3.59 A; H=364-622, L=328-363.
DR   PDB; 5GDS; X-ray; 2.10 A; H=364-622, L=328-363.
DR   PDB; 5JDU; X-ray; 1.70 A; A/C=331-363, B/D=364-622.
DR   PDB; 5L6N; X-ray; 1.63 A; H=364-622, L=328-363.
DR   PDB; 5LUW; X-ray; 1.69 A; H=364-622, L=328-363.
DR   PDB; 5LUY; X-ray; 2.24 A; H=364-622, L=328-363.
DR   PDB; 5TO3; X-ray; 2.34 A; A=318-363, B=364-621.
DR   PDB; 7KME; X-ray; 2.10 A; H=364-622, L=328-363.
DR   PDB; 8KME; X-ray; 2.10 A; 1=328-359, 2=364-620.
DR   PDBsum; 1A2C; -.
DR   PDBsum; 1A3B; -.
DR   PDBsum; 1A3E; -.
DR   PDBsum; 1A46; -.
DR   PDBsum; 1A4W; -.
DR   PDBsum; 1A5G; -.
DR   PDBsum; 1A61; -.
DR   PDBsum; 1ABI; -.
DR   PDBsum; 1ABJ; -.
DR   PDBsum; 1AD8; -.
DR   PDBsum; 1AE8; -.
DR   PDBsum; 1AFE; -.
DR   PDBsum; 1AHT; -.
DR   PDBsum; 1AI8; -.
DR   PDBsum; 1AIX; -.
DR   PDBsum; 1AWF; -.
DR   PDBsum; 1AWH; -.
DR   PDBsum; 1AY6; -.
DR   PDBsum; 1B5G; -.
DR   PDBsum; 1B7X; -.
DR   PDBsum; 1BA8; -.
DR   PDBsum; 1BB0; -.
DR   PDBsum; 1BCU; -.
DR   PDBsum; 1BHX; -.
DR   PDBsum; 1BMM; -.
DR   PDBsum; 1BMN; -.
DR   PDBsum; 1BTH; -.
DR   PDBsum; 1C1U; -.
DR   PDBsum; 1C1V; -.
DR   PDBsum; 1C1W; -.
DR   PDBsum; 1C4U; -.
DR   PDBsum; 1C4V; -.
DR   PDBsum; 1C4Y; -.
DR   PDBsum; 1C5L; -.
DR   PDBsum; 1C5N; -.
DR   PDBsum; 1C5O; -.
DR   PDBsum; 1CA8; -.
DR   PDBsum; 1D3D; -.
DR   PDBsum; 1D3P; -.
DR   PDBsum; 1D3Q; -.
DR   PDBsum; 1D3T; -.
DR   PDBsum; 1D4P; -.
DR   PDBsum; 1D6W; -.
DR   PDBsum; 1D9I; -.
DR   PDBsum; 1DE7; -.
DR   PDBsum; 1DIT; -.
DR   PDBsum; 1DM4; -.
DR   PDBsum; 1DOJ; -.
DR   PDBsum; 1DWB; -.
DR   PDBsum; 1DWC; -.
DR   PDBsum; 1DWD; -.
DR   PDBsum; 1DWE; -.
DR   PDBsum; 1DX5; -.
DR   PDBsum; 1E0F; -.
DR   PDBsum; 1EB1; -.
DR   PDBsum; 1EOJ; -.
DR   PDBsum; 1EOL; -.
DR   PDBsum; 1FPC; -.
DR   PDBsum; 1FPH; -.
DR   PDBsum; 1G30; -.
DR   PDBsum; 1G32; -.
DR   PDBsum; 1G37; -.
DR   PDBsum; 1GHV; -.
DR   PDBsum; 1GHW; -.
DR   PDBsum; 1GHX; -.
DR   PDBsum; 1GHY; -.
DR   PDBsum; 1GJ4; -.
DR   PDBsum; 1GJ5; -.
DR   PDBsum; 1H8D; -.
DR   PDBsum; 1H8I; -.
DR   PDBsum; 1HAG; -.
DR   PDBsum; 1HAH; -.
DR   PDBsum; 1HAI; -.
DR   PDBsum; 1HAO; -.
DR   PDBsum; 1HAP; -.
DR   PDBsum; 1HBT; -.
DR   PDBsum; 1HDT; -.
DR   PDBsum; 1HGT; -.
DR   PDBsum; 1HLT; -.
DR   PDBsum; 1HUT; -.
DR   PDBsum; 1HXE; -.
DR   PDBsum; 1HXF; -.
DR   PDBsum; 1IHS; -.
DR   PDBsum; 1IHT; -.
DR   PDBsum; 1JMO; -.
DR   PDBsum; 1JOU; -.
DR   PDBsum; 1JWT; -.
DR   PDBsum; 1K21; -.
DR   PDBsum; 1K22; -.
DR   PDBsum; 1KTS; -.
DR   PDBsum; 1KTT; -.
DR   PDBsum; 1LHC; -.
DR   PDBsum; 1LHD; -.
DR   PDBsum; 1LHE; -.
DR   PDBsum; 1LHF; -.
DR   PDBsum; 1LHG; -.
DR   PDBsum; 1MH0; -.
DR   PDBsum; 1MU6; -.
DR   PDBsum; 1MU8; -.
DR   PDBsum; 1MUE; -.
DR   PDBsum; 1NM6; -.
DR   PDBsum; 1NO9; -.
DR   PDBsum; 1NRN; -.
DR   PDBsum; 1NRO; -.
DR   PDBsum; 1NRP; -.
DR   PDBsum; 1NRQ; -.
DR   PDBsum; 1NRR; -.
DR   PDBsum; 1NRS; -.
DR   PDBsum; 1NT1; -.
DR   PDBsum; 1NU7; -.
DR   PDBsum; 1NU9; -.
DR   PDBsum; 1NY2; -.
DR   PDBsum; 1NZQ; -.
DR   PDBsum; 1O0D; -.
DR   PDBsum; 1O2G; -.
DR   PDBsum; 1O5G; -.
DR   PDBsum; 1OOK; -.
DR   PDBsum; 1OYT; -.
DR   PDBsum; 1P8V; -.
DR   PDBsum; 1PPB; -.
DR   PDBsum; 1QBV; -.
DR   PDBsum; 1QHR; -.
DR   PDBsum; 1QJ1; -.
DR   PDBsum; 1QJ6; -.
DR   PDBsum; 1QJ7; -.
DR   PDBsum; 1QUR; -.
DR   PDBsum; 1RD3; -.
DR   PDBsum; 1RIW; -.
DR   PDBsum; 1SB1; -.
DR   PDBsum; 1SFQ; -.
DR   PDBsum; 1SG8; -.
DR   PDBsum; 1SGI; -.
DR   PDBsum; 1SHH; -.
DR   PDBsum; 1SL3; -.
DR   PDBsum; 1SR5; -.
DR   PDBsum; 1T4U; -.
DR   PDBsum; 1T4V; -.
DR   PDBsum; 1TA2; -.
DR   PDBsum; 1TA6; -.
DR   PDBsum; 1TB6; -.
DR   PDBsum; 1TBZ; -.
DR   PDBsum; 1THP; -.
DR   PDBsum; 1THR; -.
DR   PDBsum; 1THS; -.
DR   PDBsum; 1TMB; -.
DR   PDBsum; 1TMT; -.
DR   PDBsum; 1TMU; -.
DR   PDBsum; 1TOM; -.
DR   PDBsum; 1TQ0; -.
DR   PDBsum; 1TQ7; -.
DR   PDBsum; 1TWX; -.
DR   PDBsum; 1UMA; -.
DR   PDBsum; 1UVS; -.
DR   PDBsum; 1VR1; -.
DR   PDBsum; 1VZQ; -.
DR   PDBsum; 1W7G; -.
DR   PDBsum; 1WAY; -.
DR   PDBsum; 1WBG; -.
DR   PDBsum; 1XM1; -.
DR   PDBsum; 1XMN; -.
DR   PDBsum; 1YPE; -.
DR   PDBsum; 1YPG; -.
DR   PDBsum; 1YPJ; -.
DR   PDBsum; 1YPK; -.
DR   PDBsum; 1YPL; -.
DR   PDBsum; 1YPM; -.
DR   PDBsum; 1Z71; -.
DR   PDBsum; 1Z8I; -.
DR   PDBsum; 1Z8J; -.
DR   PDBsum; 1ZGI; -.
DR   PDBsum; 1ZGV; -.
DR   PDBsum; 1ZRB; -.
DR   PDBsum; 2A0Q; -.
DR   PDBsum; 2A2X; -.
DR   PDBsum; 2A45; -.
DR   PDBsum; 2AFQ; -.
DR   PDBsum; 2ANK; -.
DR   PDBsum; 2ANM; -.
DR   PDBsum; 2B5T; -.
DR   PDBsum; 2BDY; -.
DR   PDBsum; 2BVR; -.
DR   PDBsum; 2BVS; -.
DR   PDBsum; 2BVX; -.
DR   PDBsum; 2BXT; -.
DR   PDBsum; 2BXU; -.
DR   PDBsum; 2C8W; -.
DR   PDBsum; 2C8X; -.
DR   PDBsum; 2C8Y; -.
DR   PDBsum; 2C8Z; -.
DR   PDBsum; 2C90; -.
DR   PDBsum; 2C93; -.
DR   PDBsum; 2CF8; -.
DR   PDBsum; 2CF9; -.
DR   PDBsum; 2CN0; -.
DR   PDBsum; 2FEQ; -.
DR   PDBsum; 2FES; -.
DR   PDBsum; 2GDE; -.
DR   PDBsum; 2GP9; -.
DR   PDBsum; 2H9T; -.
DR   PDBsum; 2HGT; -.
DR   PDBsum; 2HNT; -.
DR   PDBsum; 2HPP; -.
DR   PDBsum; 2HPQ; -.
DR   PDBsum; 2HWL; -.
DR   PDBsum; 2JH0; -.
DR   PDBsum; 2JH5; -.
DR   PDBsum; 2JH6; -.
DR   PDBsum; 2OD3; -.
DR   PDBsum; 2PGB; -.
DR   PDBsum; 2PGQ; -.
DR   PDBsum; 2PKS; -.
DR   PDBsum; 2PW8; -.
DR   PDBsum; 2R2M; -.
DR   PDBsum; 2THF; -.
DR   PDBsum; 2UUF; -.
DR   PDBsum; 2UUJ; -.
DR   PDBsum; 2UUK; -.
DR   PDBsum; 2V3H; -.
DR   PDBsum; 2V3O; -.
DR   PDBsum; 2ZC9; -.
DR   PDBsum; 2ZDA; -.
DR   PDBsum; 2ZDV; -.
DR   PDBsum; 2ZF0; -.
DR   PDBsum; 2ZFF; -.
DR   PDBsum; 2ZFP; -.
DR   PDBsum; 2ZFQ; -.
DR   PDBsum; 2ZFR; -.
DR   PDBsum; 2ZG0; -.
DR   PDBsum; 2ZGB; -.
DR   PDBsum; 2ZGX; -.
DR   PDBsum; 2ZHE; -.
DR   PDBsum; 2ZHF; -.
DR   PDBsum; 2ZHQ; -.
DR   PDBsum; 2ZHW; -.
DR   PDBsum; 2ZI2; -.
DR   PDBsum; 2ZIQ; -.
DR   PDBsum; 2ZNK; -.
DR   PDBsum; 2ZO3; -.
DR   PDBsum; 3B23; -.
DR   PDBsum; 3B9F; -.
DR   PDBsum; 3BEF; -.
DR   PDBsum; 3BEI; -.
DR   PDBsum; 3BF6; -.
DR   PDBsum; 3BIU; -.
DR   PDBsum; 3BIV; -.
DR   PDBsum; 3BV9; -.
DR   PDBsum; 3C1K; -.
DR   PDBsum; 3C27; -.
DR   PDBsum; 3D49; -.
DR   PDBsum; 3DA9; -.
DR   PDBsum; 3DD2; -.
DR   PDBsum; 3DHK; -.
DR   PDBsum; 3DT0; -.
DR   PDBsum; 3DUX; -.
DR   PDBsum; 3E6P; -.
DR   PDBsum; 3EE0; -.
DR   PDBsum; 3EGK; -.
DR   PDBsum; 3EQ0; -.
DR   PDBsum; 3F68; -.
DR   PDBsum; 3GIC; -.
DR   PDBsum; 3GIS; -.
DR   PDBsum; 3HAT; -.
DR   PDBsum; 3HKJ; -.
DR   PDBsum; 3HTC; -.
DR   PDBsum; 3JZ1; -.
DR   PDBsum; 3JZ2; -.
DR   PDBsum; 3K65; -.
DR   PDBsum; 3LDX; -.
DR   PDBsum; 3LU9; -.
DR   PDBsum; 3NXP; -.
DR   PDBsum; 3P17; -.
DR   PDBsum; 3P6Z; -.
DR   PDBsum; 3P70; -.
DR   PDBsum; 3PMH; -.
DR   PDBsum; 3PO1; -.
DR   PDBsum; 3QDZ; -.
DR   PDBsum; 3QGN; -.
DR   PDBsum; 3QLP; -.
DR   PDBsum; 3QTO; -.
DR   PDBsum; 3QTV; -.
DR   PDBsum; 3QWC; -.
DR   PDBsum; 3QX5; -.
DR   PDBsum; 3R3G; -.
DR   PDBsum; 3RLW; -.
DR   PDBsum; 3RLY; -.
DR   PDBsum; 3RM0; -.
DR   PDBsum; 3RM2; -.
DR   PDBsum; 3RML; -.
DR   PDBsum; 3RMM; -.
DR   PDBsum; 3RMN; -.
DR   PDBsum; 3RMO; -.
DR   PDBsum; 3S7H; -.
DR   PDBsum; 3S7K; -.
DR   PDBsum; 3SHA; -.
DR   PDBsum; 3SHC; -.
DR   PDBsum; 3SI3; -.
DR   PDBsum; 3SI4; -.
DR   PDBsum; 3SQE; -.
DR   PDBsum; 3SQH; -.
DR   PDBsum; 3SV2; -.
DR   PDBsum; 3T5F; -.
DR   PDBsum; 3TU7; -.
DR   PDBsum; 3U69; -.
DR   PDBsum; 3U8O; -.
DR   PDBsum; 3U8R; -.
DR   PDBsum; 3U8T; -.
DR   PDBsum; 3U98; -.
DR   PDBsum; 3U9A; -.
DR   PDBsum; 3UTU; -.
DR   PDBsum; 3UWJ; -.
DR   PDBsum; 3VXE; -.
DR   PDBsum; 3VXF; -.
DR   PDBsum; 4AX9; -.
DR   PDBsum; 4AYV; -.
DR   PDBsum; 4AYY; -.
DR   PDBsum; 4AZ2; -.
DR   PDBsum; 4BAH; -.
DR   PDBsum; 4BAK; -.
DR   PDBsum; 4BAM; -.
DR   PDBsum; 4BAN; -.
DR   PDBsum; 4BAO; -.
DR   PDBsum; 4BAQ; -.
DR   PDBsum; 4BOH; -.
DR   PDBsum; 4CH2; -.
DR   PDBsum; 4CH8; -.
DR   PDBsum; 4DIH; -.
DR   PDBsum; 4DII; -.
DR   PDBsum; 4DT7; -.
DR   PDBsum; 4DY7; -.
DR   PDBsum; 4E05; -.
DR   PDBsum; 4E06; -.
DR   PDBsum; 4E7R; -.
DR   PDBsum; 4H6S; -.
DR   PDBsum; 4H6T; -.
DR   PDBsum; 4HFP; -.
DR   PDBsum; 4HTC; -.
DR   PDBsum; 4HZH; -.
DR   PDBsum; 4I7Y; -.
DR   PDBsum; 4LOY; -.
DR   PDBsum; 4LXB; -.
DR   PDBsum; 4LZ1; -.
DR   PDBsum; 4LZ4; -.
DR   PDBsum; 4MLF; -.
DR   PDBsum; 4N3L; -.
DR   PDBsum; 4NZE; -.
DR   PDBsum; 4NZQ; -.
DR   PDBsum; 4O03; -.
DR   PDBsum; 4RKJ; -.
DR   PDBsum; 4RKO; -.
DR   PDBsum; 4RN6; -.
DR   PDBsum; 4THN; -.
DR   PDBsum; 4UD9; -.
DR   PDBsum; 4UDW; -.
DR   PDBsum; 4UE7; -.
DR   PDBsum; 4UEH; -.
DR   PDBsum; 4UFD; -.
DR   PDBsum; 4UFE; -.
DR   PDBsum; 4UFF; -.
DR   PDBsum; 4UFG; -.
DR   PDBsum; 4YES; -.
DR   PDBsum; 5A2M; -.
DR   PDBsum; 5AF9; -.
DR   PDBsum; 5AFY; -.
DR   PDBsum; 5AFZ; -.
DR   PDBsum; 5AHG; -.
DR   PDBsum; 5CMX; -.
DR   PDBsum; 5DO4; -.
DR   PDBsum; 5E8E; -.
DR   PDBsum; 5EDK; -.
DR   PDBsum; 5EDM; -.
DR   PDBsum; 5EW1; -.
DR   PDBsum; 5EW2; -.
DR   PDBsum; 5GDS; -.
DR   PDBsum; 5JDU; -.
DR   PDBsum; 5L6N; -.
DR   PDBsum; 5LUW; -.
DR   PDBsum; 5LUY; -.
DR   PDBsum; 5TO3; -.
DR   PDBsum; 7KME; -.
DR   PDBsum; 8KME; -.
DR   ProteinModelPortal; P00734; -.
DR   SMR; P00734; -.
DR   BioGrid; 108447; 16.
DR   DIP; DIP-6115N; -.
DR   IntAct; P00734; 10.
DR   MINT; MINT-147273; -.
DR   STRING; 9606.ENSP00000308541; -.
DR   BindingDB; P00734; -.
DR   ChEMBL; CHEMBL204; -.
DR   DrugBank; DB07211; (2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE.
DR   DrugBank; DB06850; (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide.
DR   DrugBank; DB07091; (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide.
DR   DrugBank; DB06845; (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide.
DR   DrugBank; DB07088; (S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide.
DR   DrugBank; DB07131; (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide.
DR   DrugBank; DB07095; (S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide.
DR   DrugBank; DB07897; 1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE.
DR   DrugBank; DB06878; 1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide.
DR   DrugBank; DB06947; 1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide.
DR   DrugBank; DB06869; 1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE.
DR   DrugBank; DB06929; 1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide.
DR   DrugBank; DB07400; 1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE.
DR   DrugBank; DB04771; 1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE.
DR   DrugBank; DB04772; 1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE.
DR   DrugBank; DB06854; 2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE.
DR   DrugBank; DB02193; 2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine.
DR   DrugBank; DB07277; 2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE.
DR   DrugBank; DB07278; 2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE.
DR   DrugBank; DB07105; 2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE.
DR   DrugBank; DB07366; 2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER.
DR   DrugBank; DB08254; 2-NAPHTHALENESULFONIC ACID.
DR   DrugBank; DB07718; 3-(4-HYDROXY-PHENYL)PYRUVIC ACID.
DR   DrugBank; DB07639; 3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER.
DR   DrugBank; DB07190; 3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide.
DR   DrugBank; DB07508; 4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE.
DR   DrugBank; DB07809; 4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE.
DR   DrugBank; DB08061; 4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE.
DR   DrugBank; DB03136; 4-Iodobenzo[B]Thiophene-2-Carboxamidine.
DR   DrugBank; DB07440; 4-TERT-BUTYLBENZENESULFONIC ACID.
DR   DrugBank; DB07376; 5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID).
DR   DrugBank; DB06861; 6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE.
DR   DrugBank; DB06866; 6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID.
DR   DrugBank; DB06865; 6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID.
DR   DrugBank; DB03865; 6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine.
DR   DrugBank; DB07934; [[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE.
DR   DrugBank; DB08422; [PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE.
DR   DrugBank; DB07659; AC-(D)PHE-PRO-BOROHOMOLYS-OH.
DR   DrugBank; DB07660; AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH.
DR   DrugBank; DB07658; AC-(D)PHE-PRO-BOROLYS-OH.
DR   DrugBank; DB00025; Antihemophilic Factor (Recombinant).
DR   DrugBank; DB00278; Argatroban.
DR   DrugBank; DB08624; BENZOTHIAZOLE.
DR   DrugBank; DB01766; Beta-(2-Naphthyl)-Alanine.
DR   DrugBank; DB07083; beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide.
DR   DrugBank; DB00006; Bivalirudin.
DR   DrugBank; DB06404; C1 Esterase Inhibitor (Human).
DR   DrugBank; DB09228; C1 Esterase Inhibitor (Recombinant).
DR   DrugBank; DB00100; Coagulation Factor IX (Recombinant).
DR   DrugBank; DB03159; CRA_8696.
DR   DrugBank; DB06911; D-leucyl-N-(3-chlorobenzyl)-L-prolinamide.
DR   DrugBank; DB06996; D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide.
DR   DrugBank; DB06919; D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide.
DR   DrugBank; DB07027; D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide.
DR   DrugBank; DB07133; D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide.
DR   DrugBank; DB06841; D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide.
DR   DrugBank; DB07143; D-phenylalanyl-N-benzyl-L-prolinamide.
DR   DrugBank; DB07005; D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide.
DR   DrugBank; DB06695; Dabigatran etexilate.
DR   DrugBank; DB00055; Drotrecogin alfa.
DR   DrugBank; DB03847; Gamma-Carboxy-Glutamic Acid.
DR   DrugBank; DB01767; Hemi-Babim.
DR   DrugBank; DB02351; Hirulog.
DR   DrugBank; DB00001; Lepirudin.
DR   DrugBank; DB04136; Lysophosphotidylserine.
DR   DrugBank; DB00170; Menadione.
DR   DrugBank; DB06838; methyl L-phenylalaninate.
DR   DrugBank; DB08187; METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE.
DR   DrugBank; DB06868; N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide.
DR   DrugBank; DB06942; N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide.
DR   DrugBank; DB06936; N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide.
DR   DrugBank; DB07165; N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE.
DR   DrugBank; DB06859; N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE.
DR   DrugBank; DB06853; N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide.
DR   DrugBank; DB06858; N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide.
DR   DrugBank; DB07279; N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE.
DR   DrugBank; DB07944; N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE.
DR   DrugBank; DB01123; Proflavine.
DR   DrugBank; DB04786; Suramin.
DR   DrugBank; DB05777; Thrombomodulin Alfa.
DR   DrugBank; DB04697; TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE.
DR   DrugBank; DB04898; Ximelagatran.
DR   DrugBank; DB08152; {(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate.
DR   GuidetoPHARMACOLOGY; 2362; -.
DR   MEROPS; S01.217; -.
DR   iPTMnet; P00734; -.
DR   PhosphoSitePlus; P00734; -.
DR   UniCarbKB; P00734; -.
DR   BioMuta; F2; -.
DR   DMDM; 135807; -.
DR   SWISS-2DPAGE; P00734; -.
DR   MaxQB; P00734; -.
DR   PaxDb; P00734; -.
DR   PeptideAtlas; P00734; -.
DR   PRIDE; P00734; -.
DR   TopDownProteomics; P00734; -.
DR   DNASU; 2147; -.
DR   Ensembl; ENST00000311907; ENSP00000308541; ENSG00000180210.
DR   GeneID; 2147; -.
DR   KEGG; hsa:2147; -.
DR   UCSC; uc001ndf.5; human.
DR   CTD; 2147; -.
DR   DisGeNET; 2147; -.
DR   GeneCards; F2; -.
DR   GeneReviews; F2; -.
DR   H-InvDB; HIX0026188; -.
DR   HGNC; HGNC:3535; F2.
DR   HPA; CAB016780; -.
DR   HPA; CAB018650; -.
DR   HPA; HPA051476; -.
DR   HPA; HPA054698; -.
DR   MalaCards; F2; -.
DR   MIM; 176930; gene.
DR   MIM; 188050; phenotype.
DR   MIM; 601367; phenotype.
DR   MIM; 613679; phenotype.
DR   MIM; 614390; phenotype.
DR   neXtProt; NX_P00734; -.
DR   OpenTargets; ENSG00000180210; -.
DR   Orphanet; 329217; Cerebral sinovenous thrombosis.
DR   Orphanet; 325; Congenital factor II deficiency.
DR   Orphanet; 64738; Non rare thrombophilia.
DR   PharmGKB; PA157; -.
DR   eggNOG; ENOG410IKPN; Eukaryota.
DR   eggNOG; COG5640; LUCA.
DR   GeneTree; ENSGT00760000119133; -.
DR   HOVERGEN; HBG108381; -.
DR   InParanoid; P00734; -.
DR   KO; K01313; -.
DR   OMA; GIECQLW; -.
DR   OrthoDB; EOG091G0AH5; -.
DR   PhylomeDB; P00734; -.
DR   TreeFam; TF327329; -.
DR   BRENDA; 3.4.21.5; 2681.
DR   Reactome; R-HSA-140837; Intrinsic Pathway of Fibrin Clot Formation.
DR   Reactome; R-HSA-140875; Common Pathway of Fibrin Clot Formation.
DR   Reactome; R-HSA-159740; Gamma-carboxylation of protein precursors.
DR   Reactome; R-HSA-159763; Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus.
DR   Reactome; R-HSA-159782; Removal of aminoterminal propeptides from gamma-carboxylated proteins.
DR   Reactome; R-HSA-202733; Cell surface interactions at the vascular wall.
DR   Reactome; R-HSA-375276; Peptide ligand-binding receptors.
DR   Reactome; R-HSA-381426; Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs).
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   Reactome; R-HSA-456926; Thrombin signalling through proteinase activated receptors (PARs).
DR   Reactome; R-HSA-76009; Platelet Aggregation (Plug Formation).
DR   SABIO-RK; P00734; -.
DR   SIGNOR; P00734; -.
DR   EvolutionaryTrace; P00734; -.
DR   GeneWiki; Thrombin; -.
DR   GenomeRNAi; 2147; -.
DR   PMAP-CutDB; P00734; -.
DR   PRO; PR:P00734; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000180210; -.
DR   CleanEx; HS_F2; -.
DR   ExpressionAtlas; P00734; baseline and differential.
DR   Genevisible; P00734; HS.
DR   GO; GO:0072562; C:blood microparticle; IDA:UniProtKB.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005796; C:Golgi lumen; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0008083; F:growth factor activity; TAS:BHF-UCL.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0004252; F:serine-type endopeptidase activity; IDA:UniProtKB.
DR   GO; GO:0070053; F:thrombospondin receptor activity; IDA:BHF-UCL.
DR   GO; GO:0006953; P:acute-phase response; IEA:UniProtKB-KW.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0007597; P:blood coagulation, intrinsic pathway; TAS:Reactome.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0006888; P:ER to Golgi vesicle-mediated transport; TAS:Reactome.
DR   GO; GO:0042730; P:fibrinolysis; IDA:UniProtKB.
DR   GO; GO:0050900; P:leukocyte migration; TAS:Reactome.
DR   GO; GO:0007275; P:multicellular organism development; TAS:ProtInc.
DR   GO; GO:0048712; P:negative regulation of astrocyte differentiation; IDA:BHF-UCL.
DR   GO; GO:0051918; P:negative regulation of fibrinolysis; TAS:BHF-UCL.
DR   GO; GO:0010544; P:negative regulation of platelet activation; TAS:BHF-UCL.
DR   GO; GO:0045861; P:negative regulation of proteolysis; IDA:BHF-UCL.
DR   GO; GO:0017187; P:peptidyl-glutamic acid carboxylation; TAS:Reactome.
DR   GO; GO:0030168; P:platelet activation; IDA:BHF-UCL.
DR   GO; GO:0030194; P:positive regulation of blood coagulation; IDA:BHF-UCL.
DR   GO; GO:0030307; P:positive regulation of cell growth; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0090218; P:positive regulation of lipid kinase activity; IDA:BHF-UCL.
DR   GO; GO:0014068; P:positive regulation of phosphatidylinositol 3-kinase signaling; IEA:Ensembl.
DR   GO; GO:1900738; P:positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; IDA:BHF-UCL.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; IDA:BHF-UCL.
DR   GO; GO:2000379; P:positive regulation of reactive oxygen species metabolic process; IDA:UniProtKB.
DR   GO; GO:0051281; P:positive regulation of release of sequestered calcium ion into cytosol; IDA:BHF-UCL.
DR   GO; GO:0006508; P:proteolysis; TAS:ProtInc.
DR   GO; GO:0030193; P:regulation of blood coagulation; TAS:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:Ensembl.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IDA:BHF-UCL.
DR   GO; GO:0010468; P:regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0009611; P:response to wounding; IDA:BHF-UCL.
DR   GO; GO:0006465; P:signal peptide processing; TAS:Reactome.
DR   CDD; cd00190; Tryp_SPc; 1.
DR   Gene3D; 4.10.140.10; -; 1.
DR   Gene3D; 4.10.740.10; -; 1.
DR   InterPro; IPR017857; Coagulation_fac_subgr_Gla_dom.
DR   InterPro; IPR000294; GLA_domain.
DR   InterPro; IPR000001; Kringle.
DR   InterPro; IPR013806; Kringle-like.
DR   InterPro; IPR018056; Kringle_CS.
DR   InterPro; IPR009003; Peptidase_S1_PA.
DR   InterPro; IPR001314; Peptidase_S1A.
DR   InterPro; IPR003966; Prothrombin/thrombin.
DR   InterPro; IPR018992; Thrombin_light_chain.
DR   InterPro; IPR001254; Trypsin_dom.
DR   InterPro; IPR018114; TRYPSIN_HIS.
DR   InterPro; IPR033116; TRYPSIN_SER.
DR   PANTHER; PTHR24254:SF13; PTHR24254:SF13; 1.
DR   Pfam; PF00594; Gla; 1.
DR   Pfam; PF00051; Kringle; 2.
DR   Pfam; PF09396; Thrombin_light; 1.
DR   Pfam; PF00089; Trypsin; 1.
DR   PIRSF; PIRSF001149; Thrombin; 1.
DR   PRINTS; PR00722; CHYMOTRYPSIN.
DR   PRINTS; PR00001; GLABLOOD.
DR   PRINTS; PR01505; PROTHROMBIN.
DR   SMART; SM00069; GLA; 1.
DR   SMART; SM00130; KR; 2.
DR   SMART; SM00020; Tryp_SPc; 1.
DR   SUPFAM; SSF50494; SSF50494; 1.
DR   SUPFAM; SSF57440; SSF57440; 2.
DR   SUPFAM; SSF57630; SSF57630; 1.
DR   PROSITE; PS00011; GLA_1; 1.
DR   PROSITE; PS50998; GLA_2; 1.
DR   PROSITE; PS00021; KRINGLE_1; 2.
DR   PROSITE; PS50070; KRINGLE_2; 2.
DR   PROSITE; PS50240; TRYPSIN_DOM; 1.
DR   PROSITE; PS00134; TRYPSIN_HIS; 1.
DR   PROSITE; PS00135; TRYPSIN_SER; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acute phase; Blood coagulation; Calcium;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Gamma-carboxyglutamic acid; Glycoprotein; Hemostasis; Hydrolase;
KW   Kringle; Pharmaceutical; Polymorphism; Protease; Reference proteome;
KW   Repeat; Secreted; Serine protease; Signal; Thrombophilia; Zymogen.
FT   SIGNAL        1     24       {ECO:0000255}.
FT   PROPEP       25     43       {ECO:0000269|PubMed:266717,
FT                                ECO:0000269|PubMed:8073540}.
FT                                /FTId=PRO_0000028159.
FT   CHAIN        44    622       Prothrombin.
FT                                /FTId=PRO_0000028160.
FT   PEPTIDE      44    198       Activation peptide fragment 1.
FT                                /FTId=PRO_0000028161.
FT   PEPTIDE     199    327       Activation peptide fragment 2.
FT                                /FTId=PRO_0000028162.
FT   CHAIN       328    363       Thrombin light chain.
FT                                /FTId=PRO_0000028163.
FT   CHAIN       364    622       Thrombin heavy chain.
FT                                /FTId=PRO_0000028164.
FT   DOMAIN       44     89       Gla. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00463}.
FT   DOMAIN      108    186       Kringle 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00121}.
FT   DOMAIN      213    291       Kringle 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00121}.
FT   DOMAIN      364    618       Peptidase S1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00274}.
FT   REGION      551    573       High affinity receptor-binding region
FT                                which is also known as the TP508 peptide.
FT   ACT_SITE    406    406       Charge relay system.
FT   ACT_SITE    462    462       Charge relay system.
FT   ACT_SITE    568    568       Charge relay system.
FT   SITE        198    199       Cleavage; by thrombin.
FT   SITE        327    328       Cleavage; by factor Xa.
FT   SITE        363    364       Cleavage; by factor Xa.
FT   MOD_RES      49     49       4-carboxyglutamate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00463,
FT                                ECO:0000269|PubMed:3759958,
FT                                ECO:0000269|PubMed:6305407}.
FT   MOD_RES      50     50       4-carboxyglutamate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00463,
FT                                ECO:0000269|PubMed:3759958,
FT                                ECO:0000269|PubMed:6305407}.
FT   MOD_RES      57     57       4-carboxyglutamate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00463,
FT                                ECO:0000269|PubMed:6305407}.
FT   MOD_RES      59     59       4-carboxyglutamate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00463,
FT                                ECO:0000269|PubMed:6305407}.
FT   MOD_RES      62     62       4-carboxyglutamate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00463,
FT                                ECO:0000269|PubMed:6305407}.
FT   MOD_RES      63     63       4-carboxyglutamate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00463,
FT                                ECO:0000269|PubMed:6305407}.
FT   MOD_RES      68     68       4-carboxyglutamate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00463,
FT                                ECO:0000269|PubMed:6305407}.
FT   MOD_RES      69     69       4-carboxyglutamate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00463,
FT                                ECO:0000269|PubMed:6305407}.
FT   MOD_RES      72     72       4-carboxyglutamate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00463,
FT                                ECO:0000269|PubMed:6305407}.
FT   MOD_RES      75     75       4-carboxyglutamate. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00463,
FT                                ECO:0000269|PubMed:6305407}.
FT   CARBOHYD    121    121       N-linked (GlcNAc...) (complex)
FT                                asparagine. {ECO:0000269|PubMed:14760718,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:22171320}.
FT   CARBOHYD    143    143       N-linked (GlcNAc...) (complex)
FT                                asparagine. {ECO:0000269|PubMed:14760718,
FT                                ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:22171320}.
FT   CARBOHYD    416    416       N-linked (GlcNAc...) (complex)
FT                                asparagine. {ECO:0000269|PubMed:16335952,
FT                                ECO:0000269|PubMed:19139490,
FT                                ECO:0000269|PubMed:19159218,
FT                                ECO:0000269|PubMed:19838169,
FT                                ECO:0000269|PubMed:873923}.
FT   DISULFID     60     65
FT   DISULFID     90    103
FT   DISULFID    108    186
FT   DISULFID    129    169
FT   DISULFID    157    181
FT   DISULFID    213    291
FT   DISULFID    234    274
FT   DISULFID    262    286
FT   DISULFID    336    482       Interchain (between light and heavy
FT                                chains).
FT   DISULFID    391    407
FT   DISULFID    536    550       {ECO:0000250}.
FT   DISULFID    564    594       {ECO:0000250}.
FT   VARIANT      72     72       E -> G (in FA2D; Shanghai).
FT                                {ECO:0000269|PubMed:14962227}.
FT                                /FTId=VAR_055232.
FT   VARIANT     165    165       T -> M (polymorphism; confirmed at
FT                                protein level; dbSNP:rs5896).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:22028381,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_011781.
FT   VARIANT     200    200       E -> K (in FA2D; prothrombin type 3;
FT                                variant confirmed at protein level;
FT                                dbSNP:rs62623459).
FT                                {ECO:0000269|PubMed:22028381,
FT                                ECO:0000269|PubMed:6405779}.
FT                                /FTId=VAR_006711.
FT   VARIANT     314    314       R -> C (in FA2D; Barcelona/Madrid;
FT                                dbSNP:rs121918477).
FT                                {ECO:0000269|PubMed:3771562}.
FT                                /FTId=VAR_006712.
FT   VARIANT     314    314       R -> H (in FA2D; Padua-1;
FT                                dbSNP:rs754231232).
FT                                {ECO:0000269|PubMed:7865694}.
FT                                /FTId=VAR_006713.
FT   VARIANT     380    380       M -> T (in FA2D; Himi-1;
FT                                dbSNP:rs121918481).
FT                                {ECO:0000269|PubMed:1421398}.
FT                                /FTId=VAR_006714.
FT   VARIANT     386    386       P -> T (polymorphism; confirmed at
FT                                protein level; dbSNP:rs5897).
FT                                {ECO:0000269|PubMed:10391209,
FT                                ECO:0000269|PubMed:22028381}.
FT                                /FTId=VAR_011782.
FT   VARIANT     425    425       R -> C (in FA2D; Quick-1;
FT                                dbSNP:rs121918479).
FT                                {ECO:0000269|PubMed:3242619}.
FT                                /FTId=VAR_006715.
FT   VARIANT     431    431       R -> H (in FA2D; Himi-2;
FT                                dbSNP:rs121918482).
FT                                {ECO:0000269|PubMed:1421398}.
FT                                /FTId=VAR_006716.
FT   VARIANT     461    461       R -> W (in FA2D; Tokushima;
FT                                dbSNP:rs121918478).
FT                                {ECO:0000269|PubMed:1349838,
FT                                ECO:0000269|PubMed:3567158,
FT                                ECO:0000269|PubMed:3801671}.
FT                                /FTId=VAR_006717.
FT   VARIANT     509    509       E -> A (in FA2D; Salakta/Frankfurt).
FT                                {ECO:0000269|PubMed:1354985,
FT                                ECO:0000269|PubMed:7792730}.
FT                                /FTId=VAR_006718.
FT   VARIANT     532    532       E -> Q (polymorphism; confirmed at
FT                                protein level).
FT                                {ECO:0000269|PubMed:22028381,
FT                                ECO:0000269|PubMed:873923}.
FT                                /FTId=VAR_068913.
FT   VARIANT     601    601       G -> V (in FA2D; Quick-2;
FT                                dbSNP:rs121918480).
FT                                {ECO:0000269|PubMed:2719946}.
FT                                /FTId=VAR_006719.
FT   CONFLICT      9     25       Missing (in Ref. 3; BAG64719).
FT                                {ECO:0000305}.
FT   CONFLICT     66     66       S -> N (in Ref. 4; BAD96497).
FT                                {ECO:0000305}.
FT   CONFLICT    119    119       H -> N (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    121    121       N -> S (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    164    164       T -> I (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    164    164       T -> N (in Ref. 7; CAA23842).
FT                                {ECO:0000305}.
FT   CONFLICT    176    176       V -> A (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    183    183       I -> T (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    194    195       AM -> MV (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    308    308       D -> DEE (in Ref. 9; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    335    335       D -> N (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    337    337       G -> R (in Ref. 4; BAD96495).
FT                                {ECO:0000305}.
FT   CONFLICT    349    349       D -> N (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    369    369       D -> N (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    398    398       D -> N (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    414    414       D -> N (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    485    485       D -> N (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    494    494       Q -> G (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    504    504       W -> Y (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    509    509       E -> S (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    511    511       W -> V (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    514    514       N -> D (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    529    530       PI -> AL (in Ref. 10; AA sequence).
FT                                {ECO:0000305}.
FT   CONFLICT    590    592       WGE -> AGA (in Ref. 11; AAR08143).
FT                                {ECO:0000305}.
FT   HELIX        47     60       {ECO:0000244|PDB:5EDM}.
FT   HELIX        67     74       {ECO:0000244|PDB:5EDM}.
FT   HELIX        77     89       {ECO:0000244|PDB:5EDM}.
FT   TURN         90     92       {ECO:0000244|PDB:5EDM}.
FT   HELIX        97    105       {ECO:0000244|PDB:5EDM}.
FT   STRAND      107    109       {ECO:0000244|PDB:5EDM}.
FT   TURN        112    115       {ECO:0000244|PDB:4HZH}.
FT   STRAND      124    126       {ECO:0000244|PDB:5EDK}.
FT   STRAND      128    130       {ECO:0000244|PDB:5EDK}.
FT   TURN        144    146       {ECO:0000244|PDB:5EDM}.
FT   STRAND      148    150       {ECO:0000244|PDB:4NZQ}.
FT   STRAND      167    173       {ECO:0000244|PDB:5EDM}.
FT   STRAND      177    180       {ECO:0000244|PDB:5EDM}.
FT   TURN        186    188       {ECO:0000244|PDB:4NZQ}.
FT   STRAND      191    193       {ECO:0000244|PDB:5EDM}.
FT   STRAND      211    214       {ECO:0000244|PDB:5EDM}.
FT   HELIX       216    218       {ECO:0000244|PDB:3K65}.
FT   STRAND      229    231       {ECO:0000244|PDB:4HZH}.
FT   STRAND      233    235       {ECO:0000244|PDB:4HZH}.
FT   STRAND      237    239       {ECO:0000244|PDB:4NZQ}.
FT   HELIX       240    246       {ECO:0000244|PDB:3K65}.
FT   STRAND      247    249       {ECO:0000244|PDB:5EDK}.
FT   STRAND      253    255       {ECO:0000244|PDB:5EDK}.
FT   STRAND      273    275       {ECO:0000244|PDB:3K65}.
FT   STRAND      277    279       {ECO:0000244|PDB:3K65}.
FT   STRAND      283    285       {ECO:0000244|PDB:3K65}.
FT   HELIX       295    297       {ECO:0000244|PDB:5EDM}.
FT   STRAND      322    324       {ECO:0000244|PDB:3BEI}.
FT   HELIX       326    329       {ECO:0000244|PDB:3BEI}.
FT   STRAND      330    332       {ECO:0000244|PDB:1QJ1}.
FT   TURN        334    337       {ECO:0000244|PDB:5AFY}.
FT   TURN        340    342       {ECO:0000244|PDB:5AFY}.
FT   HELIX       343    345       {ECO:0000244|PDB:5AFY}.
FT   HELIX       352    358       {ECO:0000244|PDB:5AFY}.
FT   TURN        360    362       {ECO:0000244|PDB:1NO9}.
FT   STRAND      367    369       {ECO:0000244|PDB:3SQH}.
FT   STRAND      372    375       {ECO:0000244|PDB:3QDZ}.
FT   STRAND      378    383       {ECO:0000244|PDB:5AFY}.
FT   TURN        384    387       {ECO:0000244|PDB:5AFY}.
FT   STRAND      388    395       {ECO:0000244|PDB:5AFY}.
FT   STRAND      397    403       {ECO:0000244|PDB:5AFY}.
FT   HELIX       405    407       {ECO:0000244|PDB:5AFY}.
FT   STRAND      408    410       {ECO:0000244|PDB:4DY7}.
FT   HELIX       411    413       {ECO:0000244|PDB:5AFY}.
FT   HELIX       419    421       {ECO:0000244|PDB:5AFY}.
FT   STRAND      422    427       {ECO:0000244|PDB:5AFY}.
FT   STRAND      430    433       {ECO:0000244|PDB:5AFY}.
FT   TURN        436    438       {ECO:0000244|PDB:5AFY}.
FT   STRAND      440    449       {ECO:0000244|PDB:5AFY}.
FT   TURN        455    458       {ECO:0000244|PDB:5AFY}.
FT   STRAND      464    470       {ECO:0000244|PDB:5AFY}.
FT   STRAND      475    477       {ECO:0000244|PDB:4O03}.
FT   HELIX       486    492       {ECO:0000244|PDB:5AFY}.
FT   STRAND      495    497       {ECO:0000244|PDB:5EDM}.
FT   STRAND      498    504       {ECO:0000244|PDB:5AFY}.
FT   STRAND      507    510       {ECO:0000244|PDB:4UD9}.
FT   TURN        513    515       {ECO:0000244|PDB:4CH2}.
FT   STRAND      516    518       {ECO:0000244|PDB:4CH2}.
FT   STRAND      524    530       {ECO:0000244|PDB:5AFY}.
FT   HELIX       533    538       {ECO:0000244|PDB:5AFY}.
FT   STRAND      540    542       {ECO:0000244|PDB:1MH0}.
FT   STRAND      548    551       {ECO:0000244|PDB:5AFY}.
FT   HELIX       555    557       {ECO:0000244|PDB:5AFY}.
FT   TURN        565    569       {ECO:0000244|PDB:3U8O}.
FT   STRAND      571    575       {ECO:0000244|PDB:5AFY}.
FT   TURN        577    579       {ECO:0000244|PDB:5AFY}.
FT   STRAND      582    590       {ECO:0000244|PDB:5AFY}.
FT   STRAND      592    595       {ECO:0000244|PDB:5AFY}.
FT   STRAND      596    598       {ECO:0000244|PDB:3K65}.
FT   STRAND      601    605       {ECO:0000244|PDB:5AFY}.
FT   HELIX       607    609       {ECO:0000244|PDB:5AFY}.
FT   HELIX       610    619       {ECO:0000244|PDB:5AFY}.
SQ   SEQUENCE   622 AA;  70037 MW;  8A25E1DA88208FCF CRC64;
     MAHVRGLQLP GCLALAALCS LVHSQHVFLA PQQARSLLQR VRRANTFLEE VRKGNLEREC
     VEETCSYEEA FEALESSTAT DVFWAKYTAC ETARTPRDKL AACLEGNCAE GLGTNYRGHV
     NITRSGIECQ LWRSRYPHKP EINSTTHPGA DLQENFCRNP DSSTTGPWCY TTDPTVRRQE
     CSIPVCGQDQ VTVAMTPRSE GSSVNLSPPL EQCVPDRGQQ YQGRLAVTTH GLPCLAWASA
     QAKALSKHQD FNSAVQLVEN FCRNPDGDEE GVWCYVAGKP GDFGYCDLNY CEEAVEEETG
     DGLDEDSDRA IEGRTATSEY QTFFNPRTFG SGEADCGLRP LFEKKSLEDK TERELLESYI
     DGRIVEGSDA EIGMSPWQVM LFRKSPQELL CGASLISDRW VLTAAHCLLY PPWDKNFTEN
     DLLVRIGKHS RTRYERNIEK ISMLEKIYIH PRYNWRENLD RDIALMKLKK PVAFSDYIHP
     VCLPDRETAA SLLQAGYKGR VTGWGNLKET WTANVGKGQP SVLQVVNLPI VERPVCKDST
     RIRITDNMFC AGYKPDEGKR GDACEGDSGG PFVMKSPFNN RWYQMGIVSW GEGCDRDGKY
     GFYTHVFRLK KWIQKVIDQF GE
//
